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Abstract 
A multienzyme complex contained in Bakers' yeast (Saccharomyces cerevisiae) which synthesizes CoA 
has been named the coenzyme A-synthesizing protein complex (CoA-SPC). The CoA-SPC has been 
shown to be insoluble in the crude Bakers' yeast cell lysate formed by exposing the yeast cell to ether and 
dry ice. Only after solubilization has this multienzyme complex been shown to catalyze the formation of 
bound dephospho-CoA utilizing the substrates adenosine triphosphate, D-pantothenic acid and L-
cysteine. A low molecular weight component or components of the soluble fraction of the yeast cell and 
chloride ion appears to be responsible for the solubilization of CoA-SPC. This endogenous component of 
the yeast cell is referred to as t-Factor. 
Purification of t-Factor has been accomplished by techniques which have included dialysis, ultrafiltration 
and paper, permeation, adsorption and ion-exchange chromatography. Although the t-Factor has not been 
identified, several properties have been demonstrated: (1) the molecular weight is between 400 to 1,000; 
(2) it is stable to heat at 80°C for 24 hours; (3) it is resistant to hydrolysis by trypsin and protease; (4) it is 
inactivated by ashing; and (5) has no ultraviolet absorption at 260 mu and 280 my. 
Replacement of t-Factor by commercially available compounds or solubilizing agents has failed to reveal 
its identity. A "one-step" purification of CoA-SPC may be obtained by combining partially purified t-Factor 
with insoluble yeast cell residue. 
An alternate procedure was developed for the preparation of CoA-SPC. This procedure involves the slow 
drying and rehydration of the yeast cells, but the need for t-Factor still remains. Sonic oscillation and 
passage through a french pressure cell, two of the more classical cell breakage techniques, fail to 
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ABSTRACT
A multienzyme complex contained in Bakers' yeast 
(Saccharomyces cerevisiae) which synthesizes CoA has been 
named the coenzyme A-synthesizing protein complex (CoA-SPC). 
The CoA-SPC has been shown to be insoluble in the crude 
Bakers' yeast cell lysate formed by exposing the yeast cell 
to ether and dry ice. Only after solubilization has this 
multienzyme complex been shown to catalyze the formation of 
bound dephospho-CoA utilizing the substrates adenosine tri­
phosphate, D-pantothenic acid and L-cysteine. A low mole­
cular weight component or components of the soluble fraction 
of the yeast cell and chloride ion appears to be responsible 
for the solubilization of CoA-SPC. This endogenous component 
of the yeast cell is referred to as t-Factor.
Purification of t-Factor has been accomplished by tech­
niques which have included dialysis, ultrafiltration and 
paper, permeation, adsorption and ion-exchange chromato­
graphy. Although the t-Factor has not been identified, 
several properties have been demonstrated: (1) the molecular 
weight is between 400 to 1,000; (2) it is stable to heat at 
80°C for 24 hours; (3) it is resistant to hydrolysis by 
trypsin and protease; (4) it is inactivated by ashing; and 
(5) has no ultraviolet absorption at 260 mu and 280 my.
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Replacement of t-Factor by commercially available compounds 
or solubilizing agents has failed to reveal its identity. A 
"one-step" purification of CoA-SPC may be obtained by combin­
ing partially purified t-Factor with insoluble yeast cell 
residue.
An alternate procedure was developed for the preparation 
of CoA-SPC. This procedure involves the slow drying and 
rehydration of the yeast cells, but the need for t-Factor 
still remains. Sonic oscillation and passage through a 
french pressure cell, two of the more classical cell breakage 
techniques, fail to produce active CoA-SPC preparations.
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INTRODUCTION AND LITERATURE REVIEW
A seemingly unimportant side reaction of the detoxifica­
tion of aromatic amines was found to require an unidentified, 
heat-stable, dialyzable component of the soluble extract of 
pigeon liver (1). The enzymes, catalyzing the conjugation of 
acetate to sulfanilamide, were reactivated in the presence of 
this unidentified component. The same liver extract compo­
nent was found to be identical to the coenzyme required for 
the acetylation of choline in brain extracts (2). In 1947, 
the liver extract component was named coenzyme A (CoA) to 
represent its significance in acetylation reactions (3) . 
Coenzyme A was shown not to be one of the B vitamins, but 
because CoA was inactivated by alkaline phosphatase and 
enzyme(s) from liver extract to yield a component necessary 
for the pantothenate-requiring bacteria Lactobacillus arabi- 
nosus (L. arabinosus) to thrive, CoA was considered to be a 
pantothenic acid derivative (3) . The name "Pantothenic" acid 
was derived from the Greek word meaning "everywhere". As R. 
J. Williams has demonstrated (4) , pantothenic acid can be 
extracted from many plant, animal and microorganism sources 
for the use as a growth factor. Novelli et al. (5) found
1
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that most, if not all of the cellular pantothenic acid con­
tained in animal tissues and bacterial cells, was bound in 
the form of CoA. A similar study by Brown in 1959 confirmed 
Novelli's view, but pointed out that significant amounts of 
bound pantothenic acid were contained in the form of CoA 
intermediates (6). These findings made a rather outstanding 
contribution to the field of biochemistry by bestowing a 
metabolic function to pantothenic acid. The search then 
began by a combination of chemical, enzymic and microbiolo­
gical methods to establish the complete structure of CoA. 
During the structural identification, some of the biosyn­
thetic mechanisms were suggested. The following will review 
the structural analysis and biosynthetic mechanisms of CoA.
Structure of Coenzyme A (CoA)
The fully established structure for CoA is shown in 
Figure 1. The structure is presented here showing the dif­
ferent structural components so that easy reference can be 
made during the ensuing discussion.
Pantothenate Moiety
Coenzyme A concentrates treated with clarase (a phos- 
phorlytic enzyme), papain (a saccharolytic enzyme), and pros­
tate phosphatase failed to liberate pantothenic acid ini­
tially, but after prolonged treatment, a small amount could 
be detected. Acid hydrolysis, however, did yield $-alanine 
in an amount to indicate that CoA was 10 percent pantothenic
Figure 1
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acid (3). Coenzyme A treated with intestinal phosphatase, a 
mono and diphosphoesterase, inactivated CoA so that it was 
unable to function during the acetylation of sulfanilamide, 
and the product from the treatment had little ability to 
stimulate the growth of L. arabinosus. All of the organic 
phosphate accountable to CoA was liberated by the treatment 
(5). Acetone-dried pigeon liver extract contains an en­
zyme (s) that inactivates CoA, but does not remove organic 
phosphate. Additionally, the degradation product of this 
treatment was ineffective for the growth of L. arabinosus. 
It was speculated then, that the liver extract was hydrolyz­
ing a linkage somewhere in the molecule other than at phos­
phate linkages (5) . The combination of enzymes in liver 
extract and intestinal phosphatase, were used to successfully 
inactivate CoA and liberate 85 percent to 90 percent of the 
pantothenic acid as shown by the growth of L. arabinosus. 
The structure for pantothenic acid has been defined (7) and 
is shown in the CoA model in Figure 1.
Nucleoside Moiety
Impure preparations of CoA showed strong ultraviolet 
light absorption at 260 mp. This observation suggested CoA 
may contain an adenine derivative. Formation of the picric 
acid derivative of the acid hydrolysate of CoA had a melting 
point 1°C greater than the picrate derivative formed from 
yeast adenylic acid (adenosine monophosphate? AMP) (8). The
4
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ultraviolet absorption of this impure CoA preparation sug­
gested the ratio of adenine to pantothenic acid was 2:1. 
However, preparations of CoA extracted from the fermentation 
broth of Streptomyces fradiae (S. fradiae) and purified by 
repeated adsorption and elution from charcoal (9,10), showed 
the adenine/pantothenic acid ratio was one. The more pure 
preparations of CoA were found to contain little reducing 
sugar (8) until upon acid hydrolysis pentose was detected by 
the orcinol method. The ribose was assumed to be bound to 
adenine probably as adenosine. Adenosine was confirmed in 
CoA preparations by treatment of the preparation with alka­
line phosphatase, to liberate the nucleoside, followed by 
treatment with a specific adenosine deaminase (10,11) to pro­
duce inosine plus NH^. This deaminase reaction was monitored 
by the decrease in absorptivity at 265 mp.
Pantetheine Moiety
During the early purifications of CoA (8,9), it was 
recognized that alkaline and acid hydrolysates produced an 
odor reminiscent of sulfur compounds. Sulfur content also 
increased parallel with CoA activity (9) . Whenever the CoA 
preparation was tested for the presence of sulfhydryl by the 
nitroprusside reagent, the result was negative (8). However, 
when the CoA preparation was treated with sodium cyanide* a 
reducing agent, the preparation gave a strong positive nitro­
prusside test. The suggestion was that CoA contained sulfur
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in disulfide linkage in the form of cystine (8). Acid hydro­
lysates of CoA when chromatographed on paper showed a com­
pound closely resembling cysteine that gave a positive nitro- 
prusside reaction and a positive ninhydrin reaction, indi­
cating that an amino group was present (9). Intestinal phos­
phatase treated CoA when chromatographed on paper showed 
three migrating spots that contained both pantothenic acid 
and sulfur. The fastest moving component when extracted con­
tained no adenosine, but pantothenic acid was liberated when 
the component was treated with avian liver extract; there­
fore, this suggested a split of the linkage between panto­
thenic acid and the sulfur compound (9) . At this stage of 
development, it was estimated that CoA contained two moles of 
sulfur (9), but the addition of a reduction step by zinc and 
hydrogen chloride during the purification procedure of CoA 
abolished disulfide crosslink formation and showed that CoA 
contained only one mole of sulfur relative to pantothenic 
acid (10).
A major step forward in understanding the structure of 
CoA was derived from an apparent unrelated topic. Yeast 
extracts were found to contain a factor necessary for the 
growth of Lactobacillus bulgaricus (L. bulgaricus) (12). The 
factor was found to be neither strongly acidic or basic, but 
it could be destroyed by alkali or acid. The factor named 
Lactobacillus bulgar icus factor (LBF) was found to be widely
distributed, with yeast being the richest source, and could
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be used as a growth factor by other microorganisms, in parti­
cular Lactobacillus helveticus (L. helveticus).
A possible link between LBF and CoA was suspected when 
LBF was found to be closely related or identical to the CoA 
degradation product formed with intestinal phosphatase (13). 
Additional evidence of the connection between CoA and LBF was 
shown by the fact that the CoA degradation product could 
stimulate growth of L. helveticus, and both the CoA degrada­
tion product and LBF were destroyed by avian liver extract to 
yield pantothenic acid. LBF could be substituted for panto­
thenic acid with 25 percent of the activity to grow L. arabi- 
nosus and only large amounts of pantothenic acid could grow 
L. helveticus (13).
Acid hydrolysis of LBF yielded products which gave posi­
tive ninhydrin and nitroprusside reactions. There appeared 
to be no free amino or carboxyl groups (14,15) in the unhy­
drolyzed LBF. It was suggested that a amide linkage existed 
between pantothenic acid and a mercaptoamine (or its disul­
fide) since 3-mercaptoethylamine ran closely to the nin- 
hydrin-nitroprusside positive acid hydrolyzed fragment of LBF 
(14,15). As previously mentioned, avian liver extract freed 
pantothenic acid from LBF, therefore a chemical synthesis was 
carried out using methyl pantothenate, $-mercaptoethylamine, 
and acetamide to produce a compound with a value close to 
LBF. Accordingly, LBF was then speculated to exist as N- 
(pantothenyl)-3-aminoethanol or the disulfide. The names
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pantetheine for the thiol, and pantethine for the disulfide 
were suggested for LBF (14).
The commonalities between LBF and CoA continued to be 
observed as it was shown that synthetic pantetheine could be 
converted to CoA by incubation with adenosine triphosphate 
(ATP) and pigeon liver extract (16). The acid hydrolysate of 
CoA was subjected to steam distillation and found to produce 
a ninhydrin-nitroprusside compound identical with 8-mercap- 
toethylamine by paper chromatography (17,18). The entire 
amount of sulfur contained in CoA preparations could be 
accounted by the 8-mercaptoethylamine residue (18). The 
chemical and biological considerations have made it clear 
that pantetheine was contained within the CoA molecule. The 
pantetheine moiety can be seen in Figure 1, page 3.
Phosphate Linkages
Coenzyme A contains three phosphate groups (9,10,19). 
Adenosine bears three hydroxyl groups and one amino group, 
and pantetheine has two hydroxyl groups and one sulfhydryl? 
therefore, the possible combinations of these groups as 
esters with phosphate or pyrophosphate are numerous. As with 
the other components of CoA, a combination of chemical and 
enzymic methods have proven successful for determining the 
type and position of the phosphate linkages.
The combined action of alkaline phosphatase and the 
unidentified avian liver extract have been used to liberate
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pantothenic acid from intact CoA (3,5). The liver enzyme(s) 
was known to hydrolyze the amide linkage between pantothenic 
acid and 3-mercaptoethylamine (cysteamine) (14). The phos­
phatase, being rather nonspecific, showed only that in some 
way phosphate must be linked to the pantotheinyl residue.
A CoA degradation product produced by the action of a 
liver enzyme alone was found to stimulate the growth of the 
bacterium Acetobacter suboxydans (A. suboxydans), but not to 
be stimulatory to the growth of L. arabinosus (20). The 
degradation product was believed to be identical to a panto­
thenic acid derivative from heart muscle, also known to stim­
ulate the growth of A. suboxydans (21). Since both sub­
stances' growth stimulatory ability were lost through the 
action of intestinal phosphatase (20), it was felt "Aceto­
bacter stimulatory factor" (ASF) was a simple phosphoric 
ester of pantothenic acid. The possible phosphate ester 
derivatives of pantothenic acid were synthesized (17,22,23). 
Since 2'-phosphopantothenic acid, 4'-phosphopantothenic 
acid, 2',4'-diphosphopantothenic acid, and cyclic-2',4'- 
phosphopantothenic acid could not stimulate the growth of A. 
suboxydans, it was found that ASF was not a simple mono or 
diphosphate of pantothenic acid. The synthetic derivatives 
did, however, confirm more of the structural features of CoA. 
When contained in CoA, the pantothenic acid residue has 
greater stability toward acid and alkali than the free vita­
min (17,25). The amide linkage in the synthetic derivatives
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was also found to be very stable. By comparing the rate of 
alkaline hydrolysis of the amide linkage in CoA to rates of 
hydrolysis of the amide bonds in 4 '-phosphopantothenic acid 
and 2 '-phosphopantothenic acid, the rate closely corresponded 
to 4 *-phosphopantothenic acid (4). It was suggested 4'- 
phosphopantothenic acid was contained in CoA.
4'-phosphopantothenic acid was confirmed as a structural 
component when acid and alkaline hydrolysates of CoA showed 
the presence of a perchloric-molybdate (for organic phos­
phate) positive spot with a value identical to synthetic 
4 '-phosphopantothenic acid (17). Scanning the paper with 
ultraviolet light showed no evidence that a purine ring was 
associated with 4 '-phosphopantothenic acid of the CoA hydro­
lysate. This was confirmed by the isolation and full chemi­
cal characterization of the alkaline hydrolyzed product of 
CoA (25).
Acid hydrolysis of liver enzyme treated CoA revealed the 
presence of $-mercaptoethylamine (cysteamine) (17). Combined 
with the data that the phosphate derivatives were inactivate 
for stimulating the growth of A. suboxydans, it was specu­
lated that ASF might be 4'-phosphopantetheine (17). Since it 
was difficult to purify 4'-phosphopantetheine from CoA hydro­
lysates, it was synthesized (26). Chromatography on paper 
revealed that synthetic 4 '-phosphopantetheine and the product 
of CoA hydrolysis had simiar Rf values It was found that 4'- 
phosphopantetheine isolated after paper chromatography of CoA
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hydrolysates and synthetic 4 '-phosphopantetheine were con­
vertible to CoA in the presence of ATP and partially purified 
pigeon liver extract (26,27). Only the D-isomer of the syn­
thetic 4 '-phosphopantetheine was convertible to CoA when a 
mixture of DL-41-phosphopantetheine was used (27). It was 
confirmed that the liver degradation product of CoA and ASF 
was 4 '-phosphopantetheine (27).
A pyrophosphate linkage was suspected in the structure 
of CoA when it was observed that CoA was rapidly deactivated 
by potato extract containing a pyrophosphatase (28). This 
observation was initially challenged when repeated experi­
ments failed to show a split and inactivation of CoA which 
led King and Strong (24) to present an incorrect structure 
for CoA. It has now been accepted that the misinterpretation 
was caused by a difference in the pH optimum used for the 
inactivation of CoA (29). King and Strong used Romberg's 
(30) potato nucleotide pyrophosphatase with a pH optimum near 
7.5, whereas Novelli's (29) potato CoA pyrophosphatase had a 
pH optimum near 5.0. Eventually, the issue was resolved when 
it was shown that snake venom pyrophosphatase would inacti­
vate CoA (31,32), that alkaline phosphatase inactivation 
could not be replaced by a phosphomonoesterase (30) , and 
chemical evidence for the pyrophosphate structure was 
obtained (25).
At this point, considerable advances had been made for 
determining the structure of CoA, but the nature of the
12
pyrophosphate linkage between pantetheine and adenosine were 
yet to be determined. The remaining discussion will focus on 
how this portion of the CoA structure was resolved.
The pyrophosphate linkage in CoA is the bond most easily 
hydrolyzed by the action of acid or alkali (26). When CoA is 
hydrolyzed by acid or alkali, a number of phosphoric esters 
are formed. One of the hydrolysis products was identified to 
be adenosine 5'-phosphate (5*-adenylic acid; 5'-AMP) when 
compared with a synthetic sample by paper chromatography 
(17) .
As with the establishment of the pyrophosphate linkage 
in CoA, potato pyrophosphatase (30) was used to generate a 
nucleotide degradation product identified to be adenosine 5'- 
phosphate. The adenosine 5'-phosphate was identified by the 
use of Schmidt's deaminase (11,19), an enzyme specific for 
distinguishing between adenosine 5'-phosphate and adenosine 
3'-phosphate. In addition to adenosine 5 '-phosphate, adeno­
sine was found as a product of potato pyrophosphatase. This 
was later determined to be a by-product due to contaminating 
adenosine 5'-phosphatase in the pyrophosphatase preparation 
(29) . Further purification of the potato extract resolved 
this ambiguity. The adenosine 5'-phosphate product was also 
confirmed by paper chromatography (29).
The chemistry of nucleosides and nucleotides has 
revealed a very important structural feature of CoA. It was 
found that CoA contained three moles of phosphate (9,10,19).
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One mole could be liberated by prostate phosphomonoesterase 
(19f29,32) and two moles could be liberated by intestinal 
phosphatase, an enzyme that contains diphosphoesterase acti­
vity (19,29). Since the nature of the pyrophosphate linkage 
had been established and the pyrophosphatase hydrolysis pro­
ducts yielded adenosine 5'-phosphate, the position of the 
monophosphate needed to be established. When chromatographed 
on paper nucleosides and nucleotides, unsubstituted at the 
2'- and 3'-positions can be demonstrated by a stable blue 
color when oxidized with periodate to dialdehydes and sprayed 
with Schiff's reagent (33). Intact CoA, when treated as 
described, failed to produce the stable blue color and there­
fore, it was suggested CoA was substituted with monphosphate 
at either the 2'- or 3'-position of adenosine (17). Further 
chemical methods were unavailable to resolve the position of 
the monophosphate, so enzymic methods were used.
Alkaline hydrolysis of ribonucleic acid produced two 
isomeric monophosphates of adenosine respectively, referred 
to as the 2'- and 3 * -phosphates of adenosine (34). A 
phosphatase has been isolated from barley which was specific 
for the hydrolysis of the 3 '-nucleotides, but had no action 
on either the 2'- or 5'-nucleotides (31), as opposed to 
prostate phosphatase which attacks all three phosphate sub­
stituted nucleotides. The barley enzyme hydrolyzes one 
phosphate group in CoA, but the CoA was not inactivated in 
the sulfanilamide assay (31,32). It was found that the
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dephosphorylated CoA was reactivated to CoA in the presence 
of ATP and pigeon liver extract. Using the arsenolysis 
method for the production of acetylphosphate by trans- 
acetylase, CoA was shown to be inactivated by the barley 
enzyme. It was then assumed that CoA was substituted at the 
3 '-position of adenosine.
More evidence showing that the phosphate was linked to 
the 3 '-position of the adenosine portion of CoA will be sum­
marized. By comparing the action of barley 3 1-nucleotidase 
on CoA and nicotinamide adenine dinucleotide phosphate 
(NADP), no phosphate was liberated from NADP. Nicotinamide 
adenine dinucleotide phosphate is substituted at the 2'- 
position of adenosine. Purified snake venom, when incubated 
with CoA and NADP, produced the products 3 1,5'-adenylic acid 
and 2',5'-adenylic acid (31,32), respectively. These pro­
ducts were separated by paper chromatography and isolated. 
The diphospho-adenosine fragments were incubated with barley 
3 '-nucleotidase and a specific 5'-adenylic acid deaminase 
(Schmidt's deaminase), while the decrease in absorptivity at 
265 my was monitored. The 5 '-adenylic acid from CoA was 
established by paper chromatography against an authentic 
standard. The diphosphate from CoA produced adenosine by the 
action of barley 3'-nucleotidase followed by the specific 5'- 
nucleotidase (32) , whereas the diphosphate of NADP did not 
liberate adenosine. A deaminase, taka-diastase deaminase, 
which is specific for 3'-adenylic acid, was able to deaminate
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the diphosphate product of CoA but was ineffective for deami- 
nating the 2',51-diphosphate from NADP. In the presence of 
acid, phosphate groups can migrate within the adenosine 
structure from the 2'-position to the 3'-position (34) to 
yield equilibrium mixtures. Therefore, in the presence of 
acid, NADP can be converted to the 3'-substituted form and 
the barley 3'-nucleotidase can then hydrolyze the phosphate 
group from 3'-NADP. The combined evidence therefore, showed 
CoA contains adenosine 3',5'-diphosphate which can be seen in 
Figure 1, page 3. The final structure for CoA emerged from 
the experimental evidence presented.
Biosynthesis of CoA
The structural identification of CoA through the use of 
microbiological assay of hydrolysis products suggested possi­
ble assembly mechanisms for CoA. The pathways for biosyn­
thesis in bacteria, animals, and yeast were elucidated on the 
basis of the substrate specificity of the enzymes catalyzing 
the respective metabolic reactions. The bacteria and yeast 
systems will be discussed, but the most extensive work has 
been accomplished with the purified rat liver enzymes.
Bacteria
The discussion henceforth, will only consider the enzy­
matic reactions from pantothenic acid to CoA. It was found 
when using the pantothenic acid requiring organism L. arabi- 
nosus, that CoA formation increased when pantothenic acid was
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present with casein hydrolysates (35). When individual amino
acids were tested, cystine or cysteine were the only amino
acids found to be effective. This amino acid requirement
could not be substituted for by 6-mercaptoethylamine, a known
+2component of CoA (14,15,17,18). Additionally, Mg and ATP
were required for CoA to be synthesized from pantothenic acid
and cysteine. If, however, cysteine was excluded from the
culture media, pantothenic acid was still taken up by the
cells, and free pantothenic acid could be liberated by the
action of intestinal phosphatase. The implication of this
finding was that pantothenic acid was phosphorylated. This
was confirmed by the isolation of a product from cells grown
in the presence of pantothenic acid that corresponded closely
to synthetic 4'-phosphopantothenic acid in terms of paper
chromatography (36) and lability of the amide linkage to
alkaline hydrolysis (37) . Cell free extracts of L. arabino-
sus were found to contain an enzyme for the phosphorylation
+2of D pantothenic acid in the presence of ATP and Mg (37). 
Likewise, extracts of Proteus morganii (P. morganii) con­
tained an enzyme, that when partially purified, could phos- 
phorylate pantothenic acid, pantethine and pantetheine (38). 
Additionally, the rates of phosphorylation of one substrate 
was inhibited by the addition of one of the other substrates 
(39), suggesting that the kinase activities are the property 
of a single enzyme. This kinase appeared not to phosphory- 
late pantothenoyl L-cysteine, but a homogenous pantothenate
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kinase isolated from Brevibacterium ammoniagenes (B. ammonia- 
genes) was found to have that ability, in addition to its 
other phosphorylating activities (40).
Although cysteine was required to produce CoA when pan­
tothenic acid was in the growth media of L. arabinosus, pan- 
thethine could completely replace the two substrates, sug­
gesting cysteine may participate in the formation of the 8- 
mercaptoethylamine portion of CoA (35). Extracts of acetone-
dried cells of P. morganii transformed pantothenic acid in
+2the presence of ATP, Mg and cysteine to a derivative 
inactive for the growth stimulation of pantothenic acid 
requiring Saccharomyces carlsbergensis (S. carlsbergensis), 
L. arabinosus, and Lactobacillus casei (L. casei), but was 
very effective for the growth of A. suboxydans (41). The 
derivative has since been identified to be 4'-phosphopante- 
theine (27), and it was suggested that pantothenoyl-L- 
cysteine was phosphorylated before decarboxylation to 4'- 
phosphopantetheine (41). These compounds appear to be most 
effective as growth factors and synthetic intermediates when 
present in the reduced (thiol) form (39,41,42).
Ward et al. (38) first suggested the pathway for CoA 
biosynthesis shown in Figure 2. However, the extensive work 
by Brown (43) , using P. morganii as a source, allowed enzymic 
activities to be separated and established.
Brown (39) , using ammonium sulfate fractionation and 
calcium phosphate gel, separated pantothenate kinase from
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Figure 2. Biosynthetic pathway of CoA from pantothenic acid
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p a n t o t h e n o y l - L - c y s t e i n e  s y n t h e t a s e ,  t h e  " c o u p l i n g  e n z y m e " .
The kinase phosphorylated pantothenic acid at the 4'-hydroxyl
+2position in the presence of ATP and Mg to yield 4'-phospho- 
pantothenic acid. Although the kinase could phosphorylate 
other substrates (38,40), Brown showed 4'-phosphopantothenic 
acid to be an obligate substrate for pantothenoyl-L-cysteine 
synthetase. Pantothenoyl-L-cysteine synthetase could con­
dense cysteine with only 4 '-phosphopantothenic acid, but not 
pantothenic acid (43) to produce 4 1-phosphopantothenoyl-L-
cysteine. The synthetase has a specific requirement for
+2cytidine triphosphate (CTP) and Mg . The synthetase can 
condense 8-mercaptoethylamine in the place of cysteine to 
form 4 '-phosphopantetheine, thereby by-passing the decar­
boxylation step (43). Since an enzyme had not been shown to 
exist for the decarboxylation of cysteine to 8-mercaptoethyl­
amine, this reaction probably does not occur in vivo. Phos- 
phopantothenoyl-L-cysteine decarboxylase was separated in 
P. morganii extracts by ammonium sulfate fractionation and 
found to decarboxylate 4'-phosphopantothenoyl-L-cysteine to 
41-phosphopantetheine. The dephosphorylated intermediate 
pantothenoyl-L-cysteine could not be decarboxylated, thereby 
providing further evidence that the synthetic route in Figure 
2 exists. The final stage of CoA biosynthesis was the pyro­
phosphate bond formation between 4 '-phosphopantetheine and 
5 '-AMP from ATP by dephospho-CoA pyrophosphorylase and the
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subsequent phosphorylation of dephospho-CoA in the presence 
of ATP by dephospho-CoA kinase.
Brown's proposed pathway (43) has gained support recent­
ly by studies conducted on other bacteria (44,45); for exam­
ple, Sarcina, Corynebacterium, and Brevibacterium were of 
interest because they could accumulate large amounts of CoA 
and thus provide a more economical source of commercial CoA. 
Although individual enzymes were not isolated, dried cell 
preparations were used to demonstrate enzyme activities based 
on the product formed from a particular precursor of the CoA 
pathway (45).
An alternate pathway has been shown to operate in some 
bacteria which includes pantothenoyl-L-cysteine and pante­
theine as intermediates. This alternate pathway shown in 
Figure 3 was partly supported by the accumulation of pante­
theine but not 4 '-phosphopantothenic acid when L. helveticus 
was cultured on pantothenic acid (6) . Secondly, panto- 
thenoyl-L-cysteine has been shown to be ten times as effec­
tive as pantothenic acid for stimulating the growth of A. 
suboxydans (40,41,46,47), thus suggesting a limited synthetic 
ability for the formation of the amide linkage and phosphory­
lation of the 4'-hydroxy group of pantothenic acid (46). 
Thirdly, there were detectable levels of pantothenoyl-L- 
cysteine decarboxylase in A. suboxydans (40,46), L. bulgari- 
cus (48), and a mutant strain from L. helveticus (48) . The
p a n t o t h e n o y l - L - c y s t e i n e  d e c a r b o x y l a s e  was f o u n d  t o  be







Figure 3. Alternate pathway of biosynthesis of CoA
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associated with the particulate matter after 100,000 x g 
centrifugation (48). Lastly, it has been stated above that 
pantothenic acid kinase can phosphorylate pantetheine, but if 
the alternate pathway should function to form CoA, the enzyme 
necessary for the formation of pantothenoyl-L-cysteine from 
pantothenic acid remains to be demonstrated.
Vertebrates
The biosynthetic pathway for the formation of CoA 
appears to follow the pathway proposed by Ward (38) and Brown 
(43) which is shown in Figure 2, page 18. The elucidation of 
the pathway for animals was riddled with ambiguities until 
purified enzymes from rat liver appeared to provide clear-cut 
evidence of the assembly process.
During the earlier work on the structural identification
of CoA, it was demonstrated that synthetic pantetheine could
be converted to CoA in the presence of ATP and pigeon liver
extract (16). Using fresh liver extracts, it was found that
pantetheine kinase could be precipitated with protamine sul-
+2fate (49) . The enzyme had a requirement for Mg and ATP. 
Pantetheine, after enzymatic treatment, could be converted to 
CoA by enzymes in the protamine supernatant fraction. When 
the product of the enzymatic treatment was exposed to pros­
tate phosphomonoesterase, the product could not be converted 
to CoA. Using synthetically derived phosphate esters of pan­
tetheine, only the D(+)4 1-phosphopantetheine isomer was
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convertible to CoA (49). At a pH optimum of 6.5, it was 
suggested that pantetheine kinase converted pantetheine to 
4'-phosphopantotheine.
Hoagland and Novelli (50) continued to study the biosyn­
thesis of CoA using hog liver as a convenient source of 
enzymes. They adsorbed pantetheine kinase and ATPase on 
calcium phosphate gel; and with ammonium sulfate fractiona­
tion, they were able to purify dephospho-CoA pyrophosphory- 
lase and dephospho-CoA kinase 100- and 125-fold, respectively
(50) . Dephospho-CoA pyrophosphorylase catalyzed the reaction
+2of 4 '-phosphopantetheine + ATP + Mg dephospho-CoA +
PP^, and dephospho-CoA kinase catalyzed the reaction of
+2dephospho-CoA + ATP + Mg — ► CoA + ADP. Both enzymes 
required the substrates to be in the reduced (thiol) form. 
The formation of dephospho-CoA (catalyzed by dephospho-CoA 
pyrophosphorylase) has been shown to be freely reversible by 
the dismutative formation of CoA from dephospho-CoA and 
inorganic pyrophosphate with the coupled enzyme system of the 
phosphorylase and kinase (50).
Hoagland and Novelli (50) showed that fresh rat liver 
could synthesize pantetheine from pantothenic acid in the 
presence of ATP and cysteine with the intermediate formation 
of pantothenoyl-L-cysteine that was decarboxylated. This 
information and the existence of pantetheine kinase (49) 
allowed Hoagland and Novelli to propose the pathway for CoA
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biosynthesis in mammalian tissues to be that shown in Figure 
3, page 21.
Brown (43), during his work on the CoA pathway in bac­
teria, also examined the pathway in rat liver and kidney 
extracts. Using saturated ammonium sulfate, Brown was able 
to separate pantothenic acid kinase from 4 '-phosphopanto- 
thenoyl-L-cysteine synthetase, the "coupling enzyme". The 
"coupling enzyme" could only use 4'-phosphopantothenic acid 
as a substrate to condense with cysteine. Although any 
nucleotide triphosphate could be used during the condensation 
step, ATP was preferred; the bacterial system had a strict 
requirement for CTP. The rat liver and kidney extracts con­
tained 4'-phosphopantothenoyl-L-cysteine decarboxylase acti­
vity for the formation of 4 '-phosphopantetheine and could not 
decarboxylate pantothenoyl-L-cysteine. Brown (43) pointed 
out that the analytical techniques employed by Hoagland and 
Novelli (50) could not distinguish between pantetheine and 
4 '-phosphopantetheine since they were using crude prepara­
tions contaminated with pantothenic acid kinase. Since it 
was found that rat liver and kidney extracts contained no 
enzyme for the decarboxylation of pantothenoyl-L-cysteine, it 
was concluded that the CoA pathway shown in Figure 2, page 
18, was the major pathway functioning in animals for CoA 
(43). However, Cavallini et al. (51) using pigeon liver 
extracts, suggested another sequence for the assembly of CoA:
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pantothenic acid — ► pantothenoyl-L-cysteine — ► 4'-phospho- 
pantothenoyl-L-cysteine — ► 4'-phosphopantetheine — ► CoA. 
The reaction sequence suggests 4'-phosphopantothenoyl-L- 
cysteine was a better precursor than pantothenoyl-L-cysteine 
for formation of CoA? but their observations disagreed with 
that point. They explained the observation by assuming that 
pantothenoyl-L-cysteine in some way inhibits the conversion 
of 4 '-phosphopantothenoyl-L-cysteine to CoA, but they did not 
check this point. These workers did not test pantothenic 
acid as a substrate for their kinase, but as it was shown 
later, both pantothenic acid and pantothenoyl-L-cysteine 
could be phosphorylated (53) . Wang and Kaplan (53) demon­
strated that pigeon liver extracts contained kinase activity 
for the conversion of dephospho-CoA to CoA.
The pathway for CoA biosynthesis shown in Figure 2, page 
18, was confirmed and clarified through the properties of the 
synthetic enzymes isolated and purified from rat liver.
Pantothenic acid kinase has been purified about 700-fold 
over crude extracts by a combination of step-wise procedures 
that included fractional precipitation with protamine, pH 
fractionation DEAE-Sephadex A-50 chromatography, and Sepha- 
dex G-200 gel filtration (52,54). The kinase was found to be 
a very labile enzyme which was successfully purified by 
stabilization with ATP (1 mM) and 10 percent sucrose at 
pH 5.8 (54). Although not competely homogenous, the prepara­
tion was free from ATPase and phosphatase activities which
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would have interfered during the kinetic and substrate speci­
ficity studies.
+2The kinase requires ATP -Mg 1:1 complex as an active
s u b s t r a t e .  I t  h a s  an a p p a r e n t  Km ( M i c h a e l i s  c o n s t a n t )  f o r  D -
+ 2pantothenic acid of 0.011 mM and 1 mM for ATP-Mg at the pH 
optimum 6.1 (54). The rat liver pantothenic acid kinase shows 
broad substrate specificity by the ability to phosphorylate 
pantothenic acid, pantetheine, pantothenoyl-L-cysteine (52), 
and pantothenyl alcohol (55) at similar rates. These phos- 
phorylating activities of the kinase should explain the con­
version of pantetheine and pantothenoyl-L-cysteine to CoA 
observed by Hoagland and Novelli (50) . Although pantothenyl 
alcohol can be phosphorylated by the kinase, it is probably 
first converted to pantothenic acid by liver alcohol dehydro­
genase before use as a CoA precursor (55). The ^-configura­
tion of the 2'-hydroxy form of pantothenic acid was a strict 
requirement as neither L-pantothenic acid nor 21-ketopante- 
theine were substrates of the kinase (54). Pantothenic acid 
kinase from rat liver was inhibited to various extents by 
intermediates in the CoA pathway, of which 4'-phosphopan- 
tetheine and CoA are the most potent inhibitors; 50 percent 
inhibition at 0.25 mM (54). Pantothenic acid kinase purified 
from B. ammoniagenes showed properties similar to rat liver 
pantothenic acid kinase (40), but the bacterial source 
appeared to be a much richer source of the enzyme.
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The condensation reaction between 4 '-phosphopantothenic
acid and L-cysteine is catalyzed by 4'-phosphopantothenoyl-L-
+2cysteine synthetase in the presence of Mg and ATP to form 
4 '-phosphopantothenoyl-L-cysteine (52,56). The mechanism is 
similar to the non-ribosomal formation of a peptide bond as 
in glutamine and glutathione synthesis which involve an acti­
vation step (56). The synthetase has been purified 120-fold 
over crude extracts from rat liver by protamine treatment, 
ammonium sulfate fractionation, calcium phosphate gel treat­
ment, repeated chromatography on CM-Sephadex C-50, and Sepha- 
dex G-75 gel filtration (52,56). Complete separation of the 
synthetase from pantothenic acid kinase was achieved by 
protamine treatment (52). The purified preparation was free 
of inorganic pyrophosphatase, adenylate kinase, and phospha­
tase thereby rendering an enzyme suitable for a stoichio­
metric study. The stoichiometric study of the synthetase 
reaction showed equimolar amounts of ADP, inorganic phos­
phate, and 4 '-phosphopantothenoyl-L-cysteine accompanied by 
an equimolar decrease in 4'-phosphopantothenic acid (56).
The synthetase has a molecular weight of approximately
37,000. The Km value of the synthetase is 0.071 to 0.083 mM
for 4 '-phosphopantothenic acid at the optimal pH of 7.5 (52).
Pantothenic acid could not be substituted in this reaction
and its presence did not inhibit the rate of the condensation
+2T h e  s y n t h e t a s e  r e q u i r e s  Mg f o r  i t s  a c t i o n ,  an dreaction.
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it was inhibited 50 percent by potassium chloride (KC1) and 
sodium chloride (NaCl) at 0.05 M, and completely by ethylene- 
diamine tetracetic acid (EDTA) at 1 mM and phosphate at 
0.08 M (52).
4 '-phosphopantothenoyl-L-cysteine is decarboxylated to 
4 '-phosphopantetheine by the enzyme 4'-phosphopantothenoyl- 
L-cysteine decarboxylase. The decarboxylase has been puri­
fied 110-fold from crude rat liver extracts by ammonium sul­
fate fractionation, calcium phosphate gel treatment, and 
DEAE-cellulose chromatography after aging in the cold for 
three weeks (57). This preparation was free of phosphatase 
activity.
The Km for 4 '-phosphopantothenoyl-L-cysteine is 0.133 mM 
to 0.15 mM at the optimal pH of 8.0 (57). Pantothenoyl-L- 
cysteine cannot be substituted as the substrate for the 
decarboxylase and this compound has no effect on the favored 
reaction. Although the decarboxylase cannot remove the car­
bon dioxide group from pantothenoyl-L-cysteine, it can, to a 
minor extent, remove the carboxyl moiety from dephospho-a- 
carboxy-CoA and a-carboxy-CoA (58). Dephospho-a-carboxy-CoA 
is the hypothetical intermediate if 4 '-phosphopantothenoyl- 
L-cysteine instead of 4'-phosphopantetheine were linked to 
the 5'-phosphoadenosine fragment. Dephospho-a-carboxy-CoA 
could not be formed when partially purified dephospho-CoA 
pyrophosphorylase was incubated with 4'-phosphopantothenoyl- 
L-cysteine and ATP (58).
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T h e  p u r i f i e d  d e c a r b o x y l a s e  was a c t i v a t e d  b y  c y s t e i n e  o r
glutathione suggesting a sulfhydryl group function in the
+2active site of the enzyme (57) . Neither Mg nor any other 
cofactors are required for decarboxylase activity. Although 
pyridoxal and pyridoxal phosphate inhibit the decarboxylase 
reaction (57), no requirement for pyridoxal could be demon­
strated by dialyzing the enzyme or incubating it with semi- 
carbazide. The reaction product of the decarboxylase, 4'- 
phosphopantetheine, inhibits the reaction competitively with 
a (Michaelis inhibition constant) of 0.43 mM. Adenosine 
triphosphate is also inhibitory, but ADP and AMP have no 
effect.
Dephospho-CoA pyrophosphorylase and dephospho-CoA 
kinase catalyze the pyrophosphate bond formation between 4'- 
phosphopantetheine and 5'-AMP, and the subsequent phosphory­
lation at the 3'-OH of the ribose moiety, respectively 
(50,59). This sequence leading to CoA is the only freely 
reversible part in the pathway (50) . There has been no 
report on the separation of these two enzymes. During 
Hoagland and Novelli's work (50) with hog liver where they 
purified the enzymes about 100-fold, these activities were 
contained in the same ammonium sulfate fraction. The purifi­
cation of the enzyme from the 59,000 x g supernatant of rat 
liver has been accomplished by protamine treatment, ammonium 
sulfate fractionation, calcium phosphate gel treatment,
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column chromatography on CM-cellulose and DEAE-cellulose, and 
Sephadex G-200, yielding a 248-fold purification of the pyro- 
phosphorylase and a 266-fold purification of the kinase (59). 
Because the specific activities of the enzymes remained con­
stant throughout the purification procedures, it was specu­
lated that the catalytic activities were contained in the 
same protein or that the enzyme existed as a bifunctional 
complex (59). The latter possibility has been maintained, 
since in the presence of 0.2 percent deoxycholate the kinase 
activity was lost whereas the pyrophosphorylase activity 
appears to be stimulated.
The purified enzyme preparation has an optimal pH of 8 
to 10 for the pyrophosphorylase reaction and 10 for the 
kinase reaction (59) . Previously, it was shown that 100-fold 
purified preparations had pH optima of 7.5 and 9.0, respec­
tively (50). The apparent Km values of the rat liver pyro­
phosphorylase were found to be 0.14 mM for 4'-phosphopante-
theine and 1 mM for ATP. The K values for the kinase arem
0.12 mM for dephospho-CoA and 0.36 mM for ATP. The complexed 
enzymes were found to be highly specific for their respective 
substrates (59). The pyrophosphorylase could not catalyze 
the formation of NAD from nicotinamide mononucleotide and 
ATP, and was thus shown to be distinct from NAD pyrophos­
phorylase. The kinase cannot phosphorylate NAD to NADP (53) .
. +2The enzymes from both rat liver and hog liver require Mg , 
cysteine, and reduced substrates (50,59).
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Since the pyrophosphorylase and kinase appear to exist 
in complex form, the synthetic system for CoA production may 
be more efficient. The close proximity of the catalytic 
sites to each other can prevent dilution and diffusion of the 
substrates and products within the cell.
Yeasts
The pathway for the synthesis of CoA shown in Figure 2, 
page 18, is commonly referred to as Brown's pathway for CoA 
synthesis (43). During Brown's investigations of the synthe­
tic pathways in rat liver and P. morganii (43), Bakers' yeast 
(Saccharomyces cerevisiae? S. cerevisiae) was shown to con­
tain pantothenic acid kinase, no coupling activity, but did 
show decarboxylase activity (43). The investigation stated 
that the pathway shown in Figure 2, page 18, was likely to 
operate in an organism if the organism contains at least one 
of the three enzyme activities (43) . Further work using 
Bakers' yeast for CoA synthesis remained dormant until a more 
economical method for producing commercial CoA was needed 
(44) .
Air-dried Bakers' yeast cells were found to accumulate 
large quantities of CoA from pantothenic acid, cysteine and 
AMP; however, a better system was found by using B. ammonia- 
genes cells incubated in the presence of pantothenic acid,
cysteine and ATP (44). Further examination of Bakers' yeast 
c e l l s  sh o w ed  t h a t  i n j u r e d  c e l l s  i n  t h e  p r e s e n c e  o f  a c a t i o n i c
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surfactant were most efficient for the production of CoA 
(60). It was speculated that the accumulation may have been 
due to inhibition of enzymes that degradate CoA (60), addi­
tional extraction of the product due to the detergent by 
breakdown of permeability barriers (60) , or the extraction of 
enzymes to provide extracellular synthesis of CoA (45) .
Most recently, Bucovaz et al. (61,62) have demonstrated 
a multienzyme complex from Bakers' yeast that contains all 
the catalytic activities to synthesize CoA, hence the name 
coenzyme A-synthesizing protein complex (CoA-SPC). The 
multienzyme complex catalyzes the synthesis of CoA from D- 
pantothenic acid, L-cysteine and ATP. The CoA-SPC has been 
shown to be gradually extracted or solubilized from Bakers' 
yeast cells by stirring cells, treated beforehand, with ether 
and dry ice, for a period of 18 hours (63 thru 69). The CoA- 
SPC has been purified about 200-fold by precipitating the 
crude extract with ammonium sulfate followed by Sephadex G- 
200 gel permeation chromatography (63,68,69) . The gel 
chromatography demonstrated CoA-SPC had an apparent molecular 
weight in excess of 200,000, and the presence of 0.02 mM ATP 
in the elution buffer stabilized the CoA-SPC activity 
(63,67,68). The multienzyme complex theory was advanced by 
the fact that the complex was shown to give a progressive and 
corresponding increase in catalytic activity for each of the 
three substrates as CoA-SPC was solubilized (64,68). Also, 
Sephadex G-200 chromatography (63) and polyacrylamide gel
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electrophoresis (67) showed only one major band of catalytic 
activity regardless of the substrate. In addition, the tem­
perature and pH optimum were the same for each catalytic 
activity.
The finding that CoA was synthesized in Bakers' yeast by 
a multienzyme complex, led Bucovaz et al. (61,62,65,66,68) to 
propose a new assembly sequence for the formation of CoA. 
Employing radioactively labeled forms of ATP, D-pantothenic 
acid, and L-cysteine reaction products were identified by 
paper chromatography and electrophoretic mobility (61,62,68). 
The proposed mechanism for the synthesis of CoA by CoA-SPC is 
shown in Figure 4. The heavy line represents the multienzyme 
complex. The initial reaction was believed to be between the 
$-phospate group of ATP and the 4'-hydroxyl group of D-panto- 
thenic acid resulting in the formation of CoA-SPC-bound 5'- 
ADP-4'-pantothenic acid. The y-phosphate of ATP was released 
into the reaction medium. L-Cysteine then reacts through its 
a-amino group with the carboxyl group of the pantothenic acid 
moiety of the proposed bound 5'-ADP-4'-pantothenic acid. At 
the time of reaction, cysteine was decarboxylated forming 
CoA-SPC-bound dephospho-CoA. Although not shown in Figure 4, 
dephospho-CoA was subsequently phosphorylated and released as 
CoA. The sequence of assembly provides a convenient way to 
assay the enzymatic activity of CoA-SPC (65,66,68,69). The 
enzyme was incubated in the presence of D-pantothenic acid,
o c
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incubation, the protein was precipitated with trichloroacetic 
acid and collected on a Whatman No. 3 MM filter disc. The 
radioactivity in the collected precipate reflects the amount 
of dephospho-CoA and CoA bound to the CoA-SPC.
The enzyme for the phosphorylation of dephospho-CoA to 
form CoA was demonstrated to be dephospho-CoA kinase. Alkali 
treatment of CoA-SPC recovered from reaction mixtures yielded 
the intermediate dephospho-CoA and a compound believed to be 
5 '-ADP-4'-pantothenic acid (61,62,68). Therefore, dephospho- 
CoA has been shown to be one of the two proposed CoA-SPC- 
bound intermediates. It would appear that phosphorylation of 
CoA-SPC-bound dephospho-CoA to form CoA may in some manner 
trigger its release from the multienzyme complex.
Inhibition studies of CoA-SPC activity by proposed reac­
tion products and compounds with structures related to the 
reaction products of L-cysteine or D-pantothenic acid sup­
ported the reaction sequence shown in Figure 4 (68).
Possible Regulation in the Biosynthesis of Coenzyme A
The enzymology studies on the purified enzymes of rat 
liver have provided some speculation as to the possible regu­
latory mechanisms involved in the biosynthesis of CoA. A 
scheme for the regulation of CoA synthesis is presented in 
Figure 5. In rat liver, there appears to be a considerable 
pool of the CoA intermediate 4'-phosphopantetheine, 219 
nmoles/gm (70) which corresponds to more than 0.22 mM. The
36
Pantothenic acid
Ki = 0.25 mM





K.l = 0.43 mM
4 ’-Phosphopantetheine
Dephospho-CoA CoA
Figure 5. Possible regulation in biosynthesis of CoA in 
the rat liver model.
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CoA level in rat liver was 363 nmoles/gm (70), which corre­
sponds to more than 0.36 mM. Pantothenic acid kinase was 
found to be strongly inhibited by 4'-phosphopantetheine and 
CoA at 0.25 mM (54). The liver levels of these two sub­
stances are very close to the effective inhibitory concentra­
tion, therefore suggesting that the kinase is not fully 
active in liver cells. A similar inhibition by CoA on puri­
fied pantothenic acid kinase from B. ammoniagenes (40) was 
observed. Although the inhibition was observed, it was con­
tradicted by the fact that this bacterium could accumulate 
large amounts of CoA (40) . Another possible site for the 
regulation may be 4'-phosphopantothenoyl-L-cysteine decar­
boxylase which was inhibited by 4 *-phosphopantetheine at 
0.43 mM (57).
Degradation of Coenzyme A in the Cell
Degradation of CoA by cellular enzymes had been recog­
nized early, during the structural elucidation of CoA (5,29). 
The preoccupation with structure analyses and biosynthetic 
mechanisms has left the cellular degradative mechanisms 
virtually untouched until recently.
Rat liver homogenates were found to degrade CoA rapidly, 
however, centrifugation at 100,000 x g could separate the 
degradative activity from the synthetic activity (71). CoA 
was found to be first degraded to dephospho-CoA by a non­
specific lysosomal acid phosphatase which was identified
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through the use of known inhibitors of lysosomal acid phos­
phatase (72). Inorganic phosphate, L-tartrate, and fluoride 
were found to strongly inhibit the dephosphorylation of CoA. 
Dephospho-CoA was found to be degraded by an enzyme insensi­
tive to phosphate inhibition (72). The pyrophosphate bond 
cleavage to the products 4'-phosphopantetheine and 5'-AMP was 
catalyzed by the action of a nucleotide pyrophosphatase, 
sometimes referred to as dephospho-CoA pyrophosphatase (73). 
The pyrophosphatase activity was found to be located in 
nuclear and microsomal fractions of rat liver, and parti­
cularly concentrated on the "plasma" membrane of those sub- 
cellular fractions (73). At the pH optimum of 7.8, the pyro­
phosphatase has a Km value of 0.03 M for dephospho-CoA and 
0.3 mM for CoA. This order of magnitude difference in reac­
tivity suggests that the presence of the phosphate group of 
the 3'-hydroxyl position on the ribose moiety affords CoA 
protection from action of the pyrophosphatase by sterically 
hindering access to the active site (73,74). Particularly of 
interest was the fact that NADH strongly inhibited (K^ = 4uM) 
the enzyme as did ATP and ADP (K^ = 0.02 mM) . Moderate 
inhibition was shown using 5'-CTP, 5'-AMP, and flavin adeno­
sine dinucleotide (FAD) at of 0.1 mM (73). Properties 
that differentiated the nucleotide pyrophosphatase activity 
from inorganic pyrophosphatase activity were that EDTA com­
pletely inhibited nucleotide pyrophosphatase, but inorganic 
pyrophosphate had little effect on nucleotide pyrophosphatase
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(73). Also, the pH optima of the two enzymes were different 
(73) .
The 4 '-phosphopantetheine product formed by the action 
of nucleotide pyrophosphatase may undergo dephosphorylation 
to pantetheine prior to degradation by the pantetheine­
splitting enzyme, pantetheinase (75,76). Pantetheinase has 
been highly purified from horse kidney (75) by procedures 
that included heat fractionation at 60°C, centrifugation, 
ammonium sulfate precipitation, CM-cellulose chromatography, 
DEAE-cellulose chromatography, and zone electrophoresis. The 
enzyme was found to be highly specific for pantetheine and 
did not hydrolyze any other carboamide bonds such as those in 
8-alanylcysteamine and pantothenic acid, but it can hydrolyze 
only to a minor extent 4 *-phosphopantetheine (75). Likewise, 
pantetheine was shown not to be hydrolyzed by some proteases 
(73) . Although pantothenic acid was not hydrolyzed, it was 
found to show product inhibition of the pantetheinase reac­
tion and therefore, could possibly be a regulatory point in 
the degradative pathway. At the pH optimum of 5, substrate 
inhibition was shown by pantetheine (73). The other product 
of the pantetheinase reaction was shown to be cysteamine (8- 
mercaptoethylamine). Cysteamine cannot be split off from CoA 
or dephospho-CoA as these nucleotides are not substrates for 
pantetheinase (74).
Pantetheinase contains at least one active site thiol 
group as shown by the ability for mercaptoethanol and
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dithiothreitol to activate the enzyme, and iodoacetamide to 
inactivate the enzyme (75). Investigations of the intra­
cellular distributions of pantetheinase in rat liver and 
kidney have shown that the activity was exclusive in the 
microsomal-lysososomal fraction in rat liver, and was distri­
buted to both the soluble and microsomal-lysosomal fractions 
in the kidney (76). Both the liver and kidney enzymes were 
activated by cysteine. The liver pantetheinase was found 
highly specific for pantetheine, but the kidney enzymes could 
hydrolyze pantetheine and to a lesser extent 4'-phosphopante- 
theine (76).
The combined evidence for the degradation of CoA in 
animals has shown that pantothenic acid and cysteamine are 
the final products. A summary of the degradative pathway is 
shown in Figure 6. The degradative pathway could be a means 
to dissimilate 4'-phosphopantetheine for the conversion of 
apo-fatty acid synthetase to holo-fatty acid synthetase (77). 
Since no enzyme exists for the decarboxylation of cysteine to 
cysteamine, the degradative pathway for CoA could provide the 
mechanism for cysteamine production and subsequent oxidation 
to hypotaurine (78,79).
Functional Group of Coenzyme A
The discovery of CoA (1) not only bestowed a metabolic 
function to pantothenic acid, but also a new bond for the 
transfer of certain metabolic intermediates (80). Good
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Figure 6. Possible pathway for the degradation of
CoA.
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evidence has been presented that the terminal thiol group is 
the reactive center of the CoA molecule (80). Originally, a 
partially purified pantothenic acid derivative from yeast 
appeared to be acetyl-CoA (81). Proof that the acetyl group 
was bonded to the sulfhydryl of CoA was shown by several 
characteristics: (1) sodium nitroprusside color reaction was 
indicative of an acetylmercaptan (80)? (2) lability of acety- 
lmercaptans upon treatment with mercury salts was demon­
strated; (3) the maintenance of activity following treatment 
with iodoacetate was attributed to the protection afforded 
the sulfhydryl group by the acetate; (4) on mild alkaline 
hydrolysis sulfhydryl was liberated and the acetylating 
ability was lost; and (5) changes in the ultraviolet absor­
bance at 233 my (80). These characteristics confirmed the 
belief that a thioester bond existed and the name "active 
acetate" was given to acetyl-CoA (81). The thioester bond 
chemically resembles acid anhydrides (80), and therefore has 
a high energy of hydrolysis, on the order of -8,000 cal/mole. 
The thioester bond is far more reactive than the correspond­
ing oxyester bond.
Extensive investigations have led to the discoveries 
that CoA is involved in many biological functions. For exam­
ple, two carbon units are transferred as acetyl-CoA in fatty 
acid oxidation, in the formation of citric acid from oxalo­
acetic acid, and by combining with itself to form ketone 
bodies. More complex carboxylic acids can form thioesters
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with CoA during the synthesis of long chain fatty acids and 
triglycerides. Table I (76) shows the known metabolic reac­
tions involving CoA and acyl carrier protein which depicts 
the central role that these compounds play in cellular meta­
bolism.
TABLE I
REACTIONS INVOLVING CoA AND ACYL CARRIER PROTEIN*
Reaction Enzyme
Oxidoreductase
1. Aldehyde + CoA + NAD = acetyl-CoA + NADH2 Aldehyde dehydrogenase
2. Glyoxylate + CoA + NADP = oxalyl-CoA + NADPH2 Glyoxylate dehydrogenase
3. Malonate semialdehyde + CoA + NAD(P) = 
acetyl-CoA + C02 + NAD(P)H2
Malonate semialdehyde 
dehydrogenase
4 RCO-COOH + CoA + NAD = RCO-CoA + C02 + NADH2 Branched chain a-keto acid 
dehydrogenase
5. Butyryl-CoA + oxidized cyt c = crotonyl-CoA 
+ reduced cyt c
Butyryl-CoA dehydrogenase
6. Acyl-CoA + oxidized cyt c = 2,3-dehydroacyl- 
CoA + reduced cyt c
Acyl-CoA dehydrogenase
7. Acetoacetyl-ACP + NADPH2 = 8-hydroxybutyryl- 
ACP + NADP
8-Ketoacyl-ACP reductase
8. RCH-CHCO—ACP + NADPH2 = RCH2CH2CO-ACP + NADP Enoyl-ACP reductase 
Transferase




10. Acetyl-CoA + L-glutamate = CoA + N-acetyl- 
L-glutamate
Aminoacid acetyltransferase
11. Acetyl-CoA + imidazole = CoA + 
N-acetylimidazole
Imidazole acetyltransferase
Taken from reference 76 (see "Bibliography").
TABLE I (continued)
Reaction Enzyme
12. Acetyl-CoA + 2-amino-2-deoxy-D-glucose=CoA + 
2-acetamido-2-deoxy-D-glucose
Glucosamine acetyltransferase
13. Acetyl-CoA + 2-amino-2-deoxy-D-glucose 
6-phosphate = CoA + 2-acetamido-2- 
deoxy- -glucose 6-phosphate
Glucosamine phosphate acetyl- 
transferase
14. Acetyl-CoA + arylamine = CoA + N-acetylaryl- 
amine
Arylamine acetyltransferase
15. Acetyl-CoA + choline = CoA + O-acetylcholine Choline acetyltransferase
16. Acetyl-CoA + carnitine = CoA + O-acetyl- 
carnitine
Carnitine acetyltransferase
17. Palmityl-CoA + carnitine = palmitylcarnitine 
+ CoA
Carnitine palmityltransferase
18. Acyl-CoA (<Cn q ) + carnitine = CoA + 
acylcarnitlne
Carnitine acyltransferase
19. Acetyl-CoA + orthophosphage = CoA + 
acetylphosphate
Phosphate acetyltransferase
20. Acetyl-CoA + acetyl-CoA = CoA + acetoacetyl 
CoA
Acetyl-CoA acetyltransferase
21. Acetyl-CoA + H2S = CoA + thioacetate Hydrogen sulfide acetyltrans- 
ferase




23. Acetyl-CoA + dihydrolipoate = CoA + 
6-S-acetylhydrolipoate
Lipoate acetyltransferase
24. Acetyl-CoA + glycine = CoA + N-acetylglycine Glycine acetyltransferase cn
TABLE I (continued)
Reaction
25. Phenylacetyl-CoA + L-glutamine = CoA +
a-N-phenylacetyl-L-glutamine
26. Acyl-CoA + L-glycerol 3-phosphate = CoA +
monoglyceride phosphate
27. Acyl-CoA + acetyl-CoA = CoA + 3-oxoacyl-CoA
28. Acetyl-CoA + L-aspartate = CoA + N-acetyl-
L-aspartate
29. Acetyl-CoA + $-D-galactoside = CoA +
6-acetyl-8-D-galactoside
30. Butyryl-CoA + orthophosphate = CoA +
butyrylphosphate
31. Acyl-CoA + 1,2-diglyceride = CoA +
triglyceride
32. Acetyl-CoA + propionate = acetate +
propionyl-CoA
33. Succinyl CoA + oxalate = succinate + oxalyl-
CoA
34. Acetyl-CoA + malonate = acetate + malonyl-CoA
35. Succinyl-CoA + 3-oxoacid = succinate +
3-oxoacyl-CoA
36. Succinyl CoA + 3-oxoadipate = succinate +
3-oxoadipyl-CoA
37. Acetyl-CoA + ACP = acetyl-ACP + CoA




















39. 8-Ketoacyl-CoA + ACP = 8-ketoacyl-ACP + CoA 8-Ketoacyl-CoA ACP-transferase 
Hydrolase
40. Acetyl-CoA + H20 = CoA + acetate Acetyl-CoA hydrolase
41. Palmityl-CoA + H20 = CoA + palmitate Palmityl-CoA hydrolase
42. Succinyl-CoA + H20 = CoA + succinate Succinyl-CoA hydrolase








45. Palmityl-ACP + H20 = ACP + palmitate Palmityl-ACP hydrolase 
Lyase
46. Oxalyl-CoA = formyl-CoA + C02 Oxalyl-CoA decarboxylase
47. Malonyl-CoA = acetyl-CoA + C02 Malonyl-CoA decarboxylase
48. L-Malate + CoA = acetyl-CoA + H20 + 
glyoxylate
Malate synthase
49. 3-Hydroxy-3-methylglutaryl-CoA = acetyl-CoA + 
acetoacetate
Hydroxymethylglutaryl-CoA lyas<
50. 3-Hydroxy-3-methylglutaryl-CoA + CoA = 
acetyl-CoA + H20 + acetoacetyl-CoA
Hydroxymethylglutaryl-CoA
synthase











53. L-3-Hydroxyacyl-CoA = 2,3 (or 3,4)-trans- 
enoyl-CoA + H20
Enoyl-CoA hydratase
54. 3-Hydroxy-3-methylqlutaryl-CoA = trans-3- 
methylglutaryl-CoA + H20
Methylglutaconyl-CoA hydratase
55. 8-Alanyl-CoA = acrylyl-CoA + NH^ 8-Alanyl-CoA ammonia-lyase




57. L-3-Hydroxybutyryl-CoA = D-3-hydroxybutyryl- 
CoA
3-Hydroxybutyryl-CoA epimerase
58. D-Methylmalonyl-CoA = L-methylmalonyl-CoA Methylmalonyl-CoA racemase
59. Vinylacetyl-CoA = crotonyl-CoA Vinylacetyl-CoA isomerase
60. Methylmalonyl-CoA = succinyl-CoA Methylmalonyl-CoA mutase
Lygase
61. ATP + acetate + CoA = AMP + PP^ + acetyl-Coa Acetyl-CoA synthetase
62. ATP + acid (C.-C,,) + CoA = AMP + PP. + 
acyl-CoA
Acyl-CoA (c4”cn )  synthetase
63. ATP + acid (Cc-Con) + CoA = AMP + PP. + 
acyl-CoA 6 20 1
Acyl-CoA (C6-C2q ) synthetase
TABLE I (continued)
Reaction Enzyme
64. GTP + acid + CoA = GDP + P^ + acyl-CoA
65. GTP + succinate + CoA = GDP + P. + succinyl-
CoA
66. ATP + succinate + CoA = ADP + P. + succinyl-
CoA
67. ATP + glutarate + CoA = ADP + Pi + glutaryl-
CoA
68. ATP + cholate + CoA = AMP + PP- + choloyl-
CoA
69. ATP + acetyl-CoA + C02 + H20 = ADP + Pi +
methylmalonyl-CoA
70. ATP + propionyl-CoA + C02 + H20 = ADP +
P^ + methylmalonyl-CoAz
71. ATP + 3-methylcrotonoyl-CoA + C02 + H20 =
ADP + P^ + 3-methylglutaconyl-CoA
72. Acetyl-ACP + malonyl-ACP = acetoacetyl-ACP +
ACP + C02
Acyl-CoA synthetase (GTP- 
dependent)
Succinyl-CoA synthetase (GDP) 










STATEMENT OF THE PROBLEM
Studies in the laboratory of Dr. E. T. Bucovaz utilizing 
an economical source of biological material, Bakers' yeast 
(S. cerevisiae), have revealed the presence of a multienzyme 
complex which is gradually solubilized into the 105,000 x g 
supernatant fraction of cell lysates. The multienzyme com­
plex was found to have the capacity to synthesize coenzyme A 
from the substrates ATP, D-pantothenic acid and L-cysteine. 
Concomitantly, a new assembly sequence for coenzyme A was 
shown to exist. The multienzyme complex was named the 
coenzyme A-synthesizing protein complex (CoA-SPC), because of 
its catalytic roles. During the elucidation of the new path­
way for the synthesis of coenzyme A, a convenient method for 
the assay for activity of the multienzyme complex was deve­
loped. Dephospho-CoA, the intermediate one-step prior to the 
formation of CoA, was found to remain bound to the multi­
enzyme complex. By using a radioactively labeled substrate, 
measurement of radioactivity bound to the trichloroacetic 
acid protein precipitate was indicative of CoA-SPC activity.
The yeast cell lysate is conveniently produced in quan­
tities of 1 kg to 2 kg by treatment of whole cells with a
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mixture of diethyl ether and solid carbon dioxide. The CoA- 
SPC is insoluble in the yeast cell lysate, and does not dis­
play its catalytic activities in an iji vitro system until 
converted to the soluble form. It was observed that stirring 
the yeast cell lysate for 18 hours at 4°C gradually solubi­
lized the CoA-SPC. The gradual solubilization of CoA-SPC 
appeared to indicate that the multienzyme complex is either 
trapped in sub-cellular organelles or bound in some manner to 
the insoluble components of the yeast cell lysate.
The research described in this dissertation centered 
around three primary problems which were apparent from the 
previous investigations on CoA-SPC. While working with the 
preparation of CoA-SPC, it appeared advisable to improve the 
preparation procedure; therefore, the author developed a new 
method for its preparation. In so doing, it was necessary to 
study in depth the solubilization characteristics. This 
study led to the discovery of a low molecular weight compound 
which functions in the solubilization of CoA-SPC. This com­
pound was named t-Factor. The small-scale production of the 
yeast cell lysate using diethyl ether was satisfactory for 
this research; however, when a greater quantity of CoA-SPC 
was needed, the danger associated with the use of large quan­
tities of diethyl ether was apparent. Therefore, the author 
studied and later developed an alternate method of cell lysis 
which does not require ether, and still provides an enzyma­
tically active CoA-SPC. Throughout all of the work described
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here, a greater understanding of the properties and charac­
teristics of CoA-SPC was accomplished. A better understand­
ing of CoA-SPC is important because of the nature of CoA 
production. The assembly sequence of the substrates for the 
production of CoA is significantly different from those pre­
viously reported for other systems. CoA-SPC synthesizes 
dephospho-CoA and CoA in an i_n vitro system; therefore, CoA- 
SPC provides a method for the production of CoA and 
dephospho-CoA whereby both compounds can be radioactively 
labeled at any desired position in their structure. Further­
more, considerable interest is being shown in the CoA-SPC 




Involvement of t-Factor in the Preparation of the Coenzyme A- 
synthesizing Protein Complex of Bakers' Yeast
Preparation of pellets containing CoA-SPC. Three 454 g 
cakes of Bakers* yeast (Federal Yeast Corporation, Baltimore, 
Maryland) were crumbled into a suitable glass vessel. 
Approximately 2.1 kg or 3.0 liters of anhydrous diethyl ether 
(Mallinckrodt Chemical Company, St. Louis, Missouri) were 
added, followed by the rapid addition of 6 kg of compressed 
CC^. The mixture was stirred continuously with a glass rod 
until all the yeast cells were frozen. The yeast cells were 
considered frozen when the pasty consistency of the mixture 
was converted to frozen grains, and when the original brown 
color of the yeast became a pale clay color. The frozen yeast 
cell mixture was allowed to thaw at 23°C to 24°C for seven 
hours at which time the yeast cells had been converted to a 
fluid state covered by a layer of ether. The mixture was 
transferred to a five liter flask and attached to a water 
aspirator vacuum line. The removal of ether was continued 
for eight to nine hours during which time the fluid yeast 
suspension was frozen and thawed one more time. The volume
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of the yeast suspension was approximately 1100 ml, but could 
vary depending upon the water content of the yeast. This 
suspension is referred to as the crude lysate.
The crude lysate was divided into 250 ml centrifuge 
bottles and centrifuged at 1,000 x g for 10 minutes in an 
International Centrifuge maintained at 4°C. Whole cells and 
starch from the original blocks of Bakers' yeast were dis­
carded. The remainder of the yeast suspension was divided 
into 250 ml centrifuge bottles and centrifuged in a Beckman 
Model J-21 centrifuge using a JA-14 rotor. The centrifuge 
was maintained at 4°C and the suspensions were centrifuged at 
10,000 x g for 30 minutes. The dark brown supernatant liquid 
that resulted following centrifugation was filtered through 
glass wool to remove the very prominent fat layer. This 
yielded approximately 400 ml and was referred to as the crude 
supernatant.
The pellet material resulting from the above centrifuga­
tion step was resuspended in a volume of ice cold deionized 
water equivalent to the volume of the supernatant removed. 
This first wash of the pellet material, after centrifugation, 
was discarded. A second resuspension of the pellet material 
in 400 ml of ice cold deionized water was divided into cen­
trifuge tubes so that approximately 4 g of wet pellet mate­
rial would be produced after centrifugation in a JA-20 rotor 
at 10,000 x g for 30 minutes at 4°C. The wet pellet material 
could be stored at -70°C for a period up to six months with
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neglible losses in activity. Prior to use, the pellets were 
thawed at 4°C.
Preparation of t-Factor. The crude supernatant provided 
by the initial centrifugation of the crude lysate described 
under "Preparation of pellets containing CoA-SPC," was a 
source of t-Factor. Heat fractionation of the crude superna­
tant liquid was achieved by heating a portion of the crude 
supernatant liquid in a water bath at 80°C for 10 minutes. 
The coagulated proteins were removed by centrifugation at 
10,000 x g at 4°C for 30 minutes. The resulting supernatant 
liquid had an amber color and was referred to as the heat- 
treated supernatant liquid. Both the crude supernatant 
liquid and heat-treated supernatant liquid could be stored at 
-70°C.
Assay for CoA-SPC Activity
Components of the reaction mixture. The reaction mix­
ture contained the following components: 2.76 ymoles diso­
dium ATP (Sigma Chemical Company, St. Louis, Missouri), 
0.77 ymoles calcium salt of D-pantothenic acid (ICN Pharma- 
ceuticals, Cleveland, Ohio), 0.50 ymoles L-[ S]-cysteine 
(Schwarz/Mann, Orangeburg, New York), 126,000 counts per min­
ute (cpm); 0.5 ml of buffer containing 50 mmoles Tris acetate 
(Tris-hydroxymethyl-aminomethane), pH 7.2; 2.5 mmoles potas­
sium chloride; 5 moles magnesium acetate (all buffer compo­
nents were purchased from Fischer Scientific Company, Fair
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Lawn, New Jersey); 0.05 ml of the supernatant fraction to be 
tested, and water to a total volume of 1 ml. Reaction mix­
tures without ATP served for background activity. Each assay 
was run in duplicate.
Incubation of the reaction mixture. The reaction compo­
nents were added to borosilicate glass test tubes (15 mm x 
100 mm) in no particular order, except that the enzyme was 
added prior to the water addition so that the enzyme would be 
completely rinsed into the tube. The tubes were incubated 
for one hour in a constant temperature water bath at 36°C. 
The reaction was terminated by adding 2 ml of 10 percent 
trichloroacetic acid (TCA; Fischer Scientific Company, Fair 
Lawn, New Jersey) at room temperature.
Precipitation procedure. The precipitated protein was 
further coagulated by heating the tubes in a boiling water 
bath for five minutes. The tubes were cooled to room temper­
ature prior to collection of the precipitated proteins.
Collection of protein precipitates. The protein preci­
pitates were collected by the use of a 30-port Millipore fil­
tration apparatus (Millipore Corporation, Bedford, Massachu­
setts) attached to a water aspirator pulling a vacuum of 30 
pounds per square inch. Filtration discs 25 mm in diameter 
were hand punched from Whatman No. 3 MM filter paper (What­
man, Incorporated, Clifton, New Jersey). The filter discs
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were numbered with a No. 2 lead pencil to correspond to the 
reaction tubes. With the filter discs in place, each tube 
contents were poured into the appropriate well and the tube 
rinsed into the well with approximately 2 ml of deionized 
water at room temperature. Each well was allowed to evacuate 
and the protein precipitates collected were rinsed four times 
with approximately 2 ml of deionized water per rinse. 
Following the washing procedure, the filter discs were 
removed and dried in an oven at 80°C.
Determination of Radioactivity
3 5The measurement of [ S ] was by liquid scintillation 
counting using the 14-carbon window of a Nuclear Chicago Mark 
II liquid scintillation counter that had a counting effi­
ciency of 87 percent. The dried filter discs containing the 
precipitated proteins were placed into glass scintillation 
vials (Kimble, Toledo, Ohio) and 4 ml of scintillation liquid 
was added. The scintillation liquid was that described by 
Hoskinson and Khorana (82) composed of 4 g, 2,5-diphenyl- 
oxazole (PPO), 50 mg, 1,4-bis-2-(4-methyl-5-phenyloxazolyl)- 
benzene (dimethyl-POPOP), and toluene to a final volume of 
one liter. The components for the scintillation fluid were 




CoA-SPC activity. Duplicate samples were averaged and
corrected for background by subtracting the cpm provided by
the sample to which no ATP was added. CoA-SPC activity was
35expressed as bound [ S]-dephospho-CoA since one mole of 
cysteine was needed to form one mole of dephospho-CoA. The 
following relationship was used to calculate bound dephospho- 
CoA:
(0 ,5 0  pmoles) X (cmp bound to  p ro te in  p r e c ip it a t e s ) (1000 nmoles/ymole)
126,000 cpm
35 onmoles [ S]-dephospho-CoA bound in  one hour a t 36 C .
Specific activity. Specific activity was based on the 
soluble protein concentration contained in the supernatant 
liquid following the extraction of CoA-SPC from insoluble
pellet material. Activity was determined by measuring the
35 . .nmoles of [ S]-dephospho-CoA-bound to trichloroacetic acid
protein precipitates in one hour at 36°C. Specific activity
was expressed as the nmoles of [ S]-dephospho-CoA-bound per
milligram of soluble protein per hour.
Determination of Protein
Soluble protein concentrations from yeast supernatants 
were estimated by the method of Lowry (83). Aliquots of the 
yeast supernatant material were diluted seriatim 500- and 
1000-fold with 0.1 N NaOH so that the color development would 
be within range of the standard curve. Aliquots, 0.5 ml, of
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the diluted supernatant were pipetted into duplicate tubes. 
Five milliliters of alkaline copper reagent (see page 61) 
were added to the tubes, after which the components were 
mixed with a vortex mixer and allowed to stand exactly 10 
minutes at room temperature. Following the 10 minute incuba­
tion, 0.5 ml of 1 N Folin-Ciocalteau reagent (Fischer Scien­
tific Company, Fair Lawn, New Jersey) was added and immedi­
ately mixed. The reaction mixtures were allowed to develop 
for exactly 30 minutes during which time the yellow color 
turned to a blue color. After full color development, the 
tubes were read in a Klett-Summerson photoelectric spectro­
photometer (New York, New York) using a green filter for 
obtaining the wavelength band of 500 to 570 mp. Duplicate 
Klett units were averaged and plotted on a standard curve as 
average Klett units versus bovine serum albumin concentration 
in mg/ml (see "Preparation of protein standards").
Preparation of protein standards. Thirty milligrams of 
crystalline bovine serum albumin (BSA) (Sigma Chemical Com­
pany, St. Louis, Missouri) was placed onto the surface of 
30 ml of deionized water. The BSA was allowed to stand at 4°C 
until completely dissolved, then it was transferred to a 
100 ml volumetric flask and diluted to exactly 100 ml with 
deionized water. The concentration of this solution was mea­
sured based on the specific absorbance for BSA (84) . Using a 
Gilford Spectrophotometer (Gilford Laboratories, Oberlin, 
Ohio) with the wavelength set at 280 mp, the absorbance of
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the BSA solution in a 1 cm path length quartz cuvette was 
determined. Deionized water was used as the reagent blank. 
The relationship that 1 mg BSA per ml has an absorbance of
0.66 (84) allowed the concentration of the stock BSA solution 
to be determined:
mq BSA/ml _ ABSORBANCE at 280 my
.66
Appropriate dilutions with deionized water of the above stock 
BSA solution were used to make three other protein standards. 
The other protein standards were checked at 280 m and their 
concentrations calculated based on the above relatonship. 
The standards were stored at 4°C with a few milliliters of 
chloroform to inhibit bacteria growth.
Protein standard curve. The BSA standards were allowed 
to react with the Lowry Reagents (83) as described above for 
the soluble yeast protein. A reagent blank was made by 
replacing BSA with an equivalent amount of deionized water. 
The reagent blank was not subtracted from either the stan­
dards or yeast samples, but was used as a point on the stan­
dard curve. Deionized water was used to electronically 
balance the Klett meter. For each set of yeast protein 
determinations, a set of standards was used to maintain reli­
ability and compensate for any time dependent decay of Lowry 
reagents.
Duplicate standards were averaged and plotted on graph 
paper as average Klett units versus BSA mg per ml. The points
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were fitted to the best straight line using the linear 
regression program supplied with the Hewlett-Packard table 
top computer, model 9801A (Hewlett-Packard Corporation, 
Houston, Texas).
Calculation of protein concentration. The line, gen­
erated by the BSA standards supplied a y-intercept value (b) 
and a slope value (m). By rearranging the equation for a line 
y = mx + b, where y was average Klett units and x was protein 
concentration in mg/ml, the protein concentration in a 
diluted yeast sample could be determined. The original con­
centration could be determined by simply multiplying the 
diluted soluble yeast protein concentration by the appro­
priate dilution factor. The calculation is summarized in the 
following equation:
X(mg s o lu b le  yeast p ro te in /m l) =
Y(average K le t t  u n its )  -b (y - in t e r c e p t )  x D i lu t io n  fa c to r 
m (s lo p e )
Preparation of reagents for protein determinations. The 
alkaline copper reagent was prepared by mixing the following 
reagents (83):
1. 10 ml of Na2C03-Na0H reagent prepared by dissolving 
20 g of Na2C03 and diluting to 100 ml of 1 N NaOH. The 1 N 
NaOH was prepared by dissolving 40 g of NaOH in 1000 ml of 
deionized water;
2. 90 ml of deionized water;
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3. 2 ml of one percent sodium-potassium tartrate pre­
pared by dissolving 1 g of the compound in a final volume of 
100 ml of deionized water?
4. 2 ml of 0.5 percent of CuS04 5 H20 prepared by 
dissolving 0.5 g of CuS04 5 H20 in a final volume of 100 ml 
of deionized water;
5. Deionized water was added to the 100 ml mark of a 
graduate cylinder.
The solution was mixed by pouring back and forth between 
a beaker and a graduate cylinder. The alkaline copper 
reagent was stored on ice and considered good until the solu­
tion became cloudy. The reagent was made just prior to use 
and discarded after the last protein sample was assayed. 
Large volumes of the alkaline copper reagent were obtained by 
measuring multiple volumes of the above components.
The Folin-Ciocalteau reagent was purchased as a 2 N 
solution and diluted one volume of reagent to one volume of 
deionized water. The solution was good for several months at 
4°C.
All the components for the protein determination 
reagents were purchased from Fischer Scientific Company, Fair 
Lawn, New Jersey.
Assay for t-Factor Activity by the Solubilization of CoA-SPC
The fraction of the soluble portion of the yeast cell to 
be tested was mixed with washed pellet material described
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under "Preparation of pellets containing CoA-SPC" in a volume 
of 2 ml. Larger suspension volumes could be produced as long 
as the pellet to soluble fraction ratio was maintained. To 
the suspension was added potassium chloride (KCl? Fischer 
Scientific Company, Fair Lawn, New, Jersey) so that the con­
centration was 10 mg KCl per milliliter of yeast suspension. 
The mixtures were mechanically agitated at 4°C for 18 hours 
by an overhead stirring motor, magnetic stirring motor, or by 
rocking on a Buchler shaker (Buchler Instruments, Fort Lee, 
New Jersey). These conditions were standard except where 
noted. Following the stirring step, the suspensions were 
centrifuged at 105,000 x g at 4°C for 20 minutes in a Beckman 
Model L3-50 (Beckman Instruments, Fort Lee, New Jersey) using 
the appropriate rotor for the volume of yeast supernatants. 
Control samples were handled identically, except the t-Factor 
solution was replaced by deionized water or 0.05 M sodium 
acetate buffer, pH 5.8. The supernatant produced by the cen­
trifugation step was tested for CoA-SPC activity as described 
under "Assay for CoA-SPC Activity."
Alternate Method for the Preparation of t-Factor
Three 454 g cakes of fresh Bakers' yeast were crumbled, 
by hand, into approximately four to five liters of liquid 
nitrogen. The frozen granules of yeast were thawed by 
running cold tap water over the outside of the container. 
The yeast was liquified by this process. The liquified yeast
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was frozen and thawed two more times using liquid nitrogen. 
The liquified yeast was divided into 250 ml centrifuge 
bottles and centrifuged at 10,000 x g for 30 minutes at 4°C 
as described under "Preparation of pellets containing CoA- 
SPC."
The supernatant was treated as described for the "Pre­
paration of t-Factor." Although t-Factor could be extracted, 
the pellet material produced by this process was unacceptable 
for obtaining CoA-SPC.
Filtration of the t-Factor through Dialysis Tubing
The t-Factor could be recovered from crude supernatant, 
heat treated supernatant, and CoA-SPC solution obtained 
following solubilization of the enzyme with the t-Factor by 
use of vacuum filtration (85). The tubing utilized was size 
No. 8 (Union Carbide, Chicago, Illinois). The tubing was 
first rinsed in a 250 ml beaker with ten changes of distilled 
water. One end of a length of tubing was tied with a double 
knot. The open end of the tubing was threaded through the 
hole of a No. 10 rubber stopper. A glass tube with capillary 
tubing attached was introduced into the dialysis tubing open­
ing and then through the hole in the stopper, thus forming a 
seal. The tubing was placed into a five liter side arm flask 
and stopper was fitted in the mouth of the flask. The capil­
lary tubing was placed into a solution of t-Factor and the 
flask was attached to a water aspirator. The vacuum was
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continued until the t-Factor solution no longer entered the 
dialysis tubing. The connection to the water aspirator was 
clamped off and stoppered, and the filtration was allowed to 
continue overnight at 4°C. A reservoir of t-Factor could be 
situated so that the capillary entry tube was at the bottom 
of the reservoir, and as dialysis proceeded, solution was 
replaced inside the dialysis tubing. The fluid passing 
through the tubing could be stored at -70°C and tested for 
activity as described under "Assay for t-Factor Activity by 
the Solubilization of CoA-SPC." A smaller apparatus could be 
used for smaller volumes.
Cone Filtration of t-Factor
Filtration cones (Amicon Corporation, Lexington, Massa­
chusetts) that retain molecules greater than 25,000 molecular 
weight (CF 25) were used to fractionate the heat treated 
supernatant. Filter cones were filled to capacity (7 ml) and 
centrifuged in an International Centrifuge equipped with a 
seven inch radius head at 1,000 x g at 4°C for two hours. The 
filtrate collected was tested for activity as described under 
"Assay for t-Factor Activity by the Solubilization of CoA- 
SPC."
Membrane Ultrafiltration of t-Factor
Amicon ultrafiltration membranes of the UM series were 
used to fractionate the heat treated supernatant liquid con­
taining t-Factor. The membranes employed were the UM-2 for
66
the retention of compounds greater than 1000 molecular weight 
and UM-05 for the retention of compounds greater than 500 
molecular weight. The membranes, 76 mm in diameter, were 
placed into an appropriate stirring cell, and were flushed 
with approximately 100 ml of deionized water to remove gly­
cerol and trace ultraviolet absorbing material, and to condi­
tion the membrane to the pressurized situation. Heat teated 
supernatant liquid was placed into the cell containing the 
UM-2 ultrafilter and stirred. The heat treated supernatant 
was forced through the membrane under 40 pounds per square 
inch (psi) nitrogen gas. The process was carried out at 4°C 
and the filtrate was collected and stored at -70°C. The 
filtration process was quite slow taking as long as seven 
days to filter 250 ml of supernatant liquid. When the fil­
tration was completed, the filtrate was tested as described 
under "Assay for t-Factor Activity by the Solubilization of 
CoA-SPC," and the retentate was diluted to the original 
volume with deionized water and tested for activity.
When an adequate volume of UM-2 filtrate was collected, 
the filtrate was subsequently passed through a UM-05 filter. 
Retained material and the UM-05 filtrate were tested for 
activity as described under "Assay for t-Factor Activity by 
the Solubilization of CoA-SPC."
Membranes were cleaned for reuse after 200 ml of mate­
rial had been filtered. The cleaning procedure began with 
submerging the membrane in a one percent solution of pepsin
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in 1 N HC1 for several hours at 36°C. The surface of the 
membrane was rinsed with 200 ml of five percent sodium chlo­
ride (Fischer Scientific Company, Fair Lawn, New Jersey) and 
then generously with distilled water. The membrane could be 
immediately reused or stored in 10 percent ethyl alcohol 
(Mallinckrodt Chemical Company, St. Louis, Missouri) at 4°C.
Heat Stability of t-Factor
Aliquots of the UM-05 filtrate, 2 ml in volume, were 
placed into sealed tubes and heated in a water bath at 80°C 
for a period of 24 hours. At prescribed intervals, a tube was 
removed and cooled to 4°C. After the cooling period, t- 
Factor activity was assessed as described under "Assay for t- 
Factor Activity by the Solubilization of CoA-SPC."
Proteolytic Treatment of t-Factor
A portion of the UM-05 filtrate was lyophilized in 4 ml 
aliquots to dryness. One aliquot of the filtrate was dis­
solved in 10 ml of 0.13 M ammonium bicarbonate (Fischer 
Scientific Company, Fair Lawn, New Jersey), and to this 
100 ug of trypsin, twice crystallized (Worthington Biochemi­
cal, Freehold, New Jersey) were added. The pH of the solu­
tion was adjusted to 8.0 with 1 N NH^OH (Mallinckrodt Chemi­
cal Company, St. Louis, Missouri). A control sample was 
prepared in a similar manner, except the trypsin was inacti­
vated by boiling for two minutes prior to its addition to the 
lyophilized UM-05 filtrate.
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Two additional aliquots were subjected to protease 
digestion. The protease was purified type VI obtained from 
Streptomyces griseus (Sigma Chemical Company, St. Louis, 
Missouri). To one aliquot of the lyophilized filtrate, 
dissolved in 10 ml of 0.13 M ammonium bicarbonate, 100 pg of 
protease were added and the pH adjusted to 7.2 with 1 N HC1 
(Mallinckrodt Chemical Company, St. Louis, Missouri). A con­
trol for protease was prepared identically, except the enzyme 
was boiled for two minutes prior to its addition to the lyo­
philized UM-05 filtrate.
Incubation of the samples. All four samples were incu­
bated for six hours at 37°C. During the incubation, the pH 
was monitored by testing the reaction mixture with pH paper.
Recovery of samples. Following the incubation period, 
the enzymatic reactions were terminated by boiling the reac­
tion mixtures for three minutes. Centrifugation was used to 
remove any denatured debris and the supernatant liquids were 
filtered through No. 8 tubing at 4°C against reduced pressure 
(see "Filtration of the t-Factor through Dialysis Tubing"). 
The dialysates were lyophilized to dryness and dissolved in 
4 ml of deionized water. The pH of these solutions were 
adjusted to pH 5.8 with 1 N HC1, if necessary.
Assessment of t-Factor. The solutions recovered from 
the proteolytic enzyme reaction mixtures were mixed with
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pellet material as described under "Assay of t-Factor Acti­
vity by the Solubilization of CoA-SPC."
Proteolytic Activity Assessment
Qualitative. The protease detection kit (Bio-Rad 
Laboratories, Richmond, California), utilizing the principle 
of radial diffusion in gel (86) , was used to qualitatively 
determine proteolytic activity.
Two agar gel tablets containing casein and Tris-HCl were 
placed in a 25 ml side arm flask and suspended in 15 ml 
deionized water. After 15 minutes, the suspension was mixed 
thoroughly and then heated in a boilng water bath until the 
agar gel completely dissolved. The agar solution was vacuum 
aspirated to remove trapped air. The solution was cooled to 
about 50°C and then poured onto glass Petri dishes. After 
the agar solidified, 4.0 mm uniform sample wells were punched 
into the gel. The gel contained approximately one percent 
casein at pH 7.2. Using a micropipet, the sample wells were 
filled with 10 to 30 yl of solution to be tested for proteo­
lytic activity.
Plate incubation. The agar plates were incubated at 
room temperature (20°C to 25°C) for 16 hours. During the 
incubation period, the plates were covered to prevent evapo­
ration.
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Detection. At the end of the 16-hour incubation time, 
the presence of transparent diffusion zones in the opalescent 
agar around a sample well was indicative of proteolytic acti­
vity. The diffusion zones which are indicative of proteo­
lytic digestion of casein were enhanced by overlaying the 
agar plate with a solution of three percent (v/v) acetic acid 
(Mallinckrodt Chemical Company, St. Louis, Missouri). After 
10 minutes, the plate was rinsed with water. A comparison 
could be made between identical samples applied to the agar 
plate in different volumes by measuring the diameter of the 
diffusion zone.
Controls for diffusion zone visualization. Urokinase 
provided in the protease detection kit was diluted to 600 
units per ml with deionized water. Combined were 30 yl of 
the urokinase solution and 30 yl of a serum sample. The 
solution was incubated for 15 minutes at 37°C. Following the 
incubation period, a 30 yl aliquot was removed and applied to 
a sample well of an agar plate. A sample of the incubation 
mixture served as the positive control since the plasmin con­
verted from plasminogen is proteolytically active toward 
casein. A negative control was demonstrated by applying 
30 yl of urokinase to a sample well. Following application, 
the samples were handled as described under "Plate incuba­
tion" and "Detection." Positive and negative controls were
utilized on each plate.
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Samples for qualitative detection of proteolytic acti­
vity. Samples of t-Factor were tested for proteolytic acti­
vity by the gel diffusion method. Samples of the crude 
supernatant liquid, heat treated supernatant liquid, and UM- 
05 filtrate containing t-Factor as well as CoA-SPC solubi­
lized by these fractions were tested for proteolytic 
activity.
The Effect of the Concentration of t-Factor on the Solubili­
zation of CoA-SPC.
The ultrafiltrate provided by the Amicon filtration 
through the UM-05 membrane (see "Membrane Ultrafiltration of 
t-Factor") was the source of t-Factor for this study. t- 
Factor was concentrated by lyophilizing 4 ml of the filtrate 
to dryness and then dissolving the material in 2 ml of deio­
nized water. Dilutions of the t-Factor solution were made by 
taking an appropriate aliquot of the UM-05 filtrate and dilu­
ting the material to a total volume of 2 ml with deionized 
water. The cellular t-Factor concentration was assumed to be 
that contained in the untreated UM-05 filtrate. Each of the 
solutions were handled as described under "Assay for t-Factor 
Activity by the Solubilization of CoA-SPC."
Ashing of t-Factor
The procedure, with slight modifications, for ashing t- 
Factor was that which DeRenzo (88) used for identifying
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molybdenum as the factor that stimulated the level of xan­
thine oxidase in rat intestine. Two milliliter portions of 
UM-05 filtrate (see "Membrane Ultrafiltration of t-Factor") 
were placed in clean, porcelain crucibles (Coors, Boulder, 
Colorado) . The amber fluid was evaporated with a very low 
flame. The filtrate material charred, and heavy black smoke 
evolved during the evaporation period. The residue that 
remained was charred further by increasing the intensity of 
the flame until the bottom of the crucible was heated to dull 
red. The crucible was then placed into a small electric 
muffle furnace (Thermo Electric Mfg. Co., Dubuque, Iowa) and 
heated for approximately two hours at 800°C.
Treatment of the ash. After cooling 2 ml of deionized 
water was added to the white ash and the mixture was mixed 
thoroughly. All of the ash that remained was not soluble. 
The suspension was centrifuged in a clinical centrifuge at 
room temperature and the liquid portion was tested for t- 
Factor activity as described under "Assay for t-Factor Acti­
vity by the Solubilization of CoA-SPC."
Another portion of the ashed material was suspended in 
1 N hydrochloric acid to dissolve insoluble oxides of com­
pounds produced during the ashing procedure. Most of the ash 
was soluble, but the small amount that was insoluble was 
removed by centrifugation. The acidic ash solution was 
adjusted to pH 5.8 with 10 N NaOH and tested for t-Factor as
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described under "Assay for t-Factor Activity by the Solubili­
zation of CoA-SPC."
Paper Chromatography
Development of preparative chromatograms. Descending 
paper chromatography of t-Factor was performed on 1 MM What­
man paper (56 cm x 32 cm) at room temperature. Ten milli­
liters of UM-05 filtrate were lyophilized to dryness and 
redissolved in 1 ml of deionized water. The total volume was 
applied in a narrow band onto several sheets of chromato­
graphy paper and dried with a stream of warm air.
The chromatograms were allowed to develop for 16 to 18 
hours at room temperature.
Chromatographic solvents. The following solvents (88) 
were used to develop the chromatograms: Solvent I, n-
butanol:glacial acetic acid:water (12:3:5 v/v/v)? Solvent II, 
n-butanol:glacial acetic acid:water (3:2:3 v/v/v). The sol­
vents, prior to development of the chromatogram, were placed 
in beakers and allowed to saturate the atmosphere of the 
chromatography chamber. The solvents for the systems were 
products of Mallinckrodt Chemical Company, St. Louis, 
Missouri.
Extraction of paper chromatograms. After development, 
the paper chromatograms were dried until no solvent vapors 
could be detected. A 1 cm strip was cut from each side of the
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chromatogram from the origin to the solvent front. These 
strips were sprayed with ninhydrin independently of the rest 
of the chromatograms and the migration of ninhydrin positive 
material was used as markers for segmenting the paper. The 
chromatograms were cut into segments parallel to the origin 
at the convenient breaks in the ninhydrin staining (see 
below, "Detection of separated compounds") materials.
The material on each segment was extracted by placing 
the paper into a 250 ml bottle containing 100 ml of deionized 
water at 4°C. The extraction fluid was removed and replaced 
with fresh water once during a 24-hour period. Following the 
24 hour extraction period at 4°C, the second portion of 
extraction fluid was decanted and combined with the fluid of 
the first extraction. The bottles containing wet, fragmented 
chromatography paper were centrifuged at 10,000 x g for 30 
minutes to squeeze the remaining water from the chromato­
graphy paper. The residual water was combined with the first 
two extractions and the entire volume was filtered through a 
Millipore HA 0.45 u filter to remove paper fibers.
The extracted material from each segment was lyophilized 
to dryness and dissolved in 10 ml of deionized water for 
testing as described under "Assay for t-Factor Activity by 
the Solubilization of CoA-SPC."
Qualitative paper chromatography. Purification of t- 
Factor beyond the UM-05 filtration step was monitored by
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paper chromatography using the developing solution described 
under "Chromatographic Solvents." Likewise, when it was of 
interest to know if certain compounds might be contained in a 
particular segment of a chromatogram, 20 yl of the authentic 
compounds dissolved to a concentration of 1 mg/ml were 
applied and allowed to migrate in the solvent systems.
Detection of separated compounds. At the end of the 
developing period for the particular solvent, the chromato­
grams were removed from the solvent, dried, then the sepa­
rated compunds were detected by: (1) absorption of ultra­
violet (UV) light, (2) color reaction, and (3) radioactivity 
measurement.
(1) Absorption of UV light. The chromatograms were 
exposed to a source of UV light (260 my) in a darkened room. 
All compounds containing adenine absorb UV light and can be 
located.
(2) Color reaction. The chromatograms were sprayed 
with one of the following solutions:
(a) Five milliliters 60 percent (w/w) perchloric acid, 
10 ml of 1 N hydrochloric acid, 25 ml of four percent (w/v) 
ammonium molybdate, and water to 100 ml. Compounds contain­
ing phosphate esters appeared as blue spots when the sprayed 
chromatograms were heated or exposed to UV light as reported 
by Hanes and Isherood (89).
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(b) Compounds containing SH-groups or disulfide groups 
were detected with the nitroprusside spray described by 
Toennies and Kolb (90). The nitroprusside spray consists of 
two reagents: (1) 1.5 g sodium nitroprusside mixed in 5 ml 
of 2 N sulfuric acid plus 95 ml methanol plus 10 ml of 28 
percent ammonia, then filtered and the collected filtrate was 
used in the detection of SH-containing compounds; (2) two 
percent NaCN in 95 percent methanol was used following nitro­
prusside treatment to detect disulfide-containing compounds. 
The chromatograms were dipped in reagent (1) and while still 
damp were dipped next in reagent (2). The position of com­
pounds containing SH-groups or disulfide groups is indicated 
by red spots (89).
(c) The ninhydrin spray consisted of 0.5 g 1,2,3-tri- 
ketohydrindene in 100 ml acetone (91). Heating the sprayed 
chromatograms at 75°C for one minute caused violet colored 
spots to appear indicating the position of a-amino acids.
(3) Radioactivity measurements. When desired, each 
dried developed chromatogram was cut into successive segments 
one-half inch in length, then each segment was placed in a 
vial and the radioactivity measured as described under 
"Determination of Radioactivity."
Permeation Chromatography of t-Factor on Sephadex G-10
Preparation of the column. Approximately 50 g of Sepha­
dex G 10 fine grade with particle size 40-120 u (Pharmacia,
77
Piscataway, New Jersey), were equilibrated for three hours in 
approximately twice its volume of deionized water. Following 
the three hour period, the gel beads were degassed by vacuum. 
After settling, any super fine material was aspirated away. 
Part of the equilibration volume was removed so that a smooth 
slurry remained. A column of bed dimensions 0.9 cm x 163 cm 
was prepared, pouring the gel slurry onto a cushion of 20 ml 
of deionized water. After column packing was complete, a 
flow rate of 1 ml per minute was maintained with a Buchler 
peristalic pump (Buchler Instruments, Fort Lee, New Jersey). 
The column was maintained at room temperature throughout its 
preparation and usage. Between fractionations the column was 
treated with 0.001 M EDTA to prevent microbial growth.
The following defined volumes were determined for the 
column:
Vj_ = total bed volume; calculated by the equation of the
2volume of a cylinder V = irr 1;
VQ = void volume? by monitoring the elution of the blue 
dextran (Pharmacia, Piscataway, New Jersey) peak. One milli­
liter of a solution 2 mg/ml in blue dextran was applied to 
the column for this measurement.
Elution method. Ten milliliters of UM-05 filtrate was 
lyophilized to dryness and redissolved in 1 ml of deionized 
water. The total volume, plus 0.5 ml rinse were placed onto 
t h e  c o lu m n  bed  s u r f a c e .  When the solution had penetrated the
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bed, the elution was started by supplying deionized water via 
the peristalic pump at a flow rate of 1 ml per minute. The 
column could be eluted with 0.03 M KC1 with no difference in 
elution pattern noted? however, water was the preferred 
eluent since the additional salt provided by the KC1 could 
not be conveniently removed. The column was monitored by 
allowing the effluent to pass through a 1 mm path length flow 
cell monitored at 260 mp by a Beckman Acta II Dual Beam spec­
trophotometer (Beckman Instruments, Fullerton, California). 
Air was used for the reference beam. In addition to record­
ing the elution pattern at 260 my, 5 ml fractions were 
collected in a refrigerated fraction collector.
Assay method. The elution volume (V ) for t-Factor was 
» e
determined by pooling fractions collected from the column, 
reducing the volume by lyophilization and redissolving the 
particular pool to a concentration approximately that applied 
to the column. Each pool was tested for t-Factor activity as 
described under "Assay for t-Factor Activity by the Solubili­
zation of CoA-SPC."
Molecular Weight Estimation of t-Factor
The molecular weight range for the components contained 
in the Sephadex G-10 pool that contained t-Factor were esti­
mated using a calibration curve plotted as the logarithm of 
molecular weight versus the ratio of Ve/VQ , a technique simi­
lar to the one employed by Marzullo (92). The calibration
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curve was produced by the elution of compounds of known mole­
cular weights and different enough in molecular weight so 
they could be conveniently separated by the G-10 column. For 
this purpose, blue dextran (molecular weight >200,000), NADP 
(molecular weight 743), adenosine diphosphate (ADP? molecular 
weight 427), AMP (molecular weight 347), uridine (molecular 
weight 243), and nicotinamide (molecular weight 123) were 
chosen. All of these compounds, except blue dextran, were 
purchased from Sigma Chemical Company, St. Louis, Missouri.
The Sephadex G-10 was reequilibrated with several column 
volumes of 0.03 M KC1. Each of the compounds for the cali­
bration curve were dissolved to a concentration of 2 mg/ml in 
0.03 M KC1. Each compound was applied to the column indivi­
dually and eluted to confirm the order at which they emerged 
from the column. The compounds were monitored at 260 my 
through a 1 mm flow cell; the peak of the elution pattern for 
the compounds was considered its V . All the compounds were 
mixed, except blue dextran, at a concentration of 2 mg/ml. 
The mixture was applied and eluted from the column. The 
elution volume of blue dextran was considered the void volume 
(VQ) of the column and the ratio of the elution volume to the 
void volume (V /V ) for each compound was calculated relative 
to blue dextran. The relationship between molecular weight 
and Ve/VQ was plotted on semi-logarithmic paper. The approx­
imate molecular weight range of t-Factor was estimated by 
plotting the Ve/VQ of the pool on the calibration curve.
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Treatment of t-Factor with Charcoal
The UM-05 filtrate was treated with charcoal to remove 
the 260 my absorbing material. The procedure for the adsorp­
tion was essentially that of Bergkvist (93) and Persson (94). 
The charcoal pellets were six to fourteen mesh activated 
petroleum base obtained from Matheson, Coleman and Bell 
(Norwood, Ohio). Before use, the charcoal was washed several 
times on a funnel with each of the following solvents: 50 
percent aqueous ethanol containing two percent concentrated 
ammonia hydroxide; 1 N hydrochloric acid? and deionized 
water. Following the rinse with water, the charcoal was 
suctioned dry and considered ready for use.
The ultraviolet absorption at 260 my in a 1 cm quartz 
cuvette was measured for the UM-05 filtrate using deionized 
water as the reagent blank. The UM-05 filtrate was combined 
with the charcoal in the ratio, 1 ml filtrate to 1 g char­
coal. The mixture was stirred for 30 minutes at 4°C. Follow­
ing the stirring period, the fluid was collected from the 
charcoal by suction filtration and was referred to as the 
"charcoal extract". The charcoal was resuspended several 
times in a total of 500 ml of cold deionized water, and these 
washes were combined with the "charcoal extract". The 
"charcoal extract" and washes were concentrated by evapora­
tion at 40°C, so that concentration of the extract was close 
to the original applied to the charcoal.
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The charcoal extracted with water was suspended and 
eluted several times on a Buchner funnel with a total volume 
of 500 ml of cold 25 percent aqueous ethanol containing 0.5 
percent concentrated ammonium hydroxide. The "charcoal 
eluate" was evaporated at 40°C to dryness and redissolved in 
deionized water to approximately the original concentration 
of the applied UM-05 filtrate. The pH of the solution was 
adjusted to 5.8 with 1 N hydrochloric acid, if necessary.
The ultraviolet absorption at 260 mu of the "charcoal 
extract" and "charcoal eluate" were determined to assess the 
removal of nucleotide compounds by the charcoal adsorption 
procedure.
Assay. Both the "charcoal extract" and "charcoal 
eluate" were tested for activity as described under "Assay 
for t-Factor Activity by the Solubilization of CoA-SPC."
Treatment of t-Factor with Ion-Exchange Resin
The large amino acid and peptide pool contained in the 
"charcoal extract" was subjected to batch ion-exchange chro­
matography (95). The "charcoal extract" was applied to 
Amberlite IR-120 cation exchange resin (Rohm & Haas Comapny, 
Philadelphia, Pennsylvania) in the hydrogen (H+) form. The 
ratio 1 ml "charcoal extract" to 3 g IR-120 was used.
The Amberlite IR-120 was washed several times on a 
Buchner funnel with deionized water followed by several 
washes with 1 N acetic acid. The pH of the "charcoal
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extract" was lowered to pH 3.1 with glacial acetic acid. The 
pH adjusted "charcoal extract" and IR-120 resin were stirred 
together for a period of two hours at 4°C. The "ion-exchange 
extract" was obtained by suction filtration followed by 
several washes of the ion-exchange resin with a total of 
200 ml of cold deionized water. The combined "ion-exchange 
extract" was concentrated by evaporation at 40°C. The "ion- 
exchange eluate" was formed by eluting the resin on a Buchner 
funnel with a total of 200 ml of 1.5 N ammonium hydroxide. 
The "ion-exchange eluate" was concentrated by rotary evapora­
tion and the pH adjusted to 5.8 with 1 N hydrochloric acid.
Assay. Both the "ion-exchange extract" and the "ion- 
exchange eluate" were tested for t-Factor as described under 
"Assay for t-Factor Activity by the Solubilization of CoA- 
SPC."
The Effect of Various Salts on the Recovery of CoA-SPC
The following salts were tested for their ability to 
replace KC1 for the enhancement of the solubilization of CoA- 
SPC by t-Factor: sodium chloride (NaCl), magnesium chloride 
(MgCl2 ) , calcium chloride (CaCl2)# manganese chloride (MnCl2), 
lithium chloride (LiCl), potassium acetate (KC2H202), sodium 
acetate (NaC2H202), potassium iodide (KI), sodium sulfate 
(Na2S0^), potassium nitrate (KNO^), and calcium phosphate 
(Ca2 (PO^)2). All analytical reagents were purchased from J.
T. Baker Chemical Company, Phillipsburg, New Jersey.
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The dichloride salts were dissolved in UM-05 filtrate 
containing t-Factor so that the chloride concentration was 
equivalent to the chloride concentration when KC1 and t- 
Factor were mixed as described under "Assay for t-Factor 
Activity by the Solubilization of CoA-SPC." The salts with­
out a chloride anion were dissolved in t-Factor so that the 
concentration was 10 mg/ml of yeast suspension.
Controls were samples of yeast pellet material mixed 
with t-Factor but without salt addition, and pellet material 
mixed with salt and deionized water without t-Factor.
Assay. The t-Factor solutions with various salts and 
controls were tested as described under "Assay for t-Factor 
Activity by the Solubilization of CoA-SPC."
Estimation of Endogenous Chlor ide
The mercurimetric method of Schales and Schales (96) was 
used for the estimation of chloride in UM-05 filtrate con­
taining t-Factor. The method is a titration based on the 
ability to detect excess free mercuric ions after all the 
chloride ion is combined with the mercuric ion. The excess 
free mercuric ions are detected by the purple end-point color 
formed in the presence of diphenylcarbazone.
Reagents. 0.01 N mercuric nitrate (Mallinckrodt Chemi­
cal Company, St. Louis, Missouri) was prepared by dissolving 
2.9 to 3.0 g of mercuric nitrate in a few hundred milliliters
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of deionized water with the addition of 20 ml of 2 N nitric 
acid (J. T. Baker Chemical Company, Phillipsburg, New 
Jersey). The solution was made up with deionized water up to 
1000 ml.
Diphenylcarbazone indicator (Eastman Kodak Company, 
Rochester, New York) was made by dissolving 0.4 g in 100 ml 
of 95 percent ethyl alcohol.
The chloride standard was made by dissolving 584.5 mg of 
sodium chloride in deionized water up to 1000 ml. This solu­
tion contained 0.355 mg of chloride per milliliter.
Standardization of mercuric nitrate. Triplicate sam­
ples of 2 ml aliquots of the chloride standard in 25 ml 
Erlenmeyer flasks were titrated with the mercuric nitrate 
solution from a micro burette. Four drops of the indicator 
solution were added to each sample. Blank titrations were 
made by replacing the chloride standard with deionized water. 
The blank titration was subtracted from the milliliters of 
mercuric nitrate solution needed to titrate the chloride 
standard. The titrations were averaged and the number of 
milligrams of chloride which react with 1.0 ml of mercuric 
nitrate solution was calculated.
Sample titrations. Samples of the UM-05 filtrate were 
handled as the chloride standards above. Although the amber 
color of the filtrate obscurred the purple end-point, it 
could be detected. The number of milliliters of standardized
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mercuric nitrate solution needed to titrate a sample was used 
to calculate the milligrams per milliliter of chloride in a 
sample.
Assessment of t-Factor Purity
An estimation of the extent to which t-Factor was puri­
fied as compared to that in the crude supernatant, was based 
on the weight of total lyophilized solids contained in any 
particular fraction and on the extent it solubilized CoA-SPC.
Testing Known Compounds for t-Factor Activity
The compounds shown in Table X, page 119 ("Results and 
Discussion"), were tested for their ability to be substituted 
for t-Factor by the method described under "Assay for t- 
Factor Activity by the Solubilization of CoA-SPC." All com­
ponents were the best analytical reagent available from Sigma 
Chemical Company, St. Louis, Missouri.
Alternate Procedure for the Preparation of CoA-SPC from 
Bakers 1 Yeast
Estimation of yeast cell volume. A weighed amount of 
fresh Bakers* yeast was suspended in a known volume of deion­
ized water. The total volume of the yeast cells and water was 
noted. The difference between the total volume and the vol­
ume of water added was considered the approximate yeast cell 
volume. It was from this volume that dried yeast cell
86
residues (to be described) were diluted for extraction of 
CoA-SPC.
Drying the yeast cells. Thirty grams of fresh com­
pressed Bakers' yeast was weighed into tared plastic petri 
dishes. The yeast was crumbled and spread evenly over the 
surface of the dishes. The yeast cells were placed at 4°C, 
room temperature (24°C), and in an oven at 50°C. At 12-hour 
intervals, a plate at each temperature was removed and 
weighed to determine the percent of weight remaining. When 
the most appropriate drying period was determined, yeast 
cells were dried for that length of time for routine prepara­
tions and examination of other variables.
Rehydration of dried yeast cell residue. Dried yeast 
cell residues were ground with a porcelain mortar and pestle 
at 24°C to a particle size range of 38 y to 425 y. Deionized 
water was added to dried, ground yeast cell residues to 
obtain the original wet weight before drying. Alternatively, 
water could be added to obtain the original yeast cell volume 
before drying. Potassium chloride was added to the smooth, 
uniformly suspended yeast residue at 10 mg/ml of yeast sus­
pension. The water for rehydration was maintained at 4°C 
except where noted.
Solubilization of CoA-SPC. The rehydrated yeast cell 
residues and KC1 mixtures were stirred for 18 hours at 4°C.
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Alternative stirring temperatures were examined to see if the 
time for solubilization of CoA-SPC could be shortened.
Assays of yeast cell extract. Following the 18-hour 
stirring step, the mixtures were centrifuged at 105,000 x g 
for one hour at 4°C. The supernatant liquid recovered was 
assayed for protein content as described under "Determination 
of Protein" and for CoA-SPC activity as described under 




Following the removal of the ether from the Bakers'
yeast cells, a portion of the liquified yeast cell lysate was
centrifuged to obtain the crude supernatant liquid (Materials
and Methods, "Preparation of pellets containing CoA-SPC").
This crude supernatant was assayed for CoA-SPC activity by
measuring the formation of [ S]-dephospho-CoA-bound from the
35substrates ATP, D-pantothenic acid and [ S]-L-cysteine. The 
crude supernatant fraction is shown in Table II as "stirring 
time, zero hours." Although this fraction contains protein 
which has been solubilized from the yeast cells, no CoA-SPC 
activity was detected. However, as shown in Table II, CoA- 
SPC activity gradually appeared after stirring the yeast cell 
lysate at 4°C in the presence of 10 mg KC1 per milliliter of 
yeast lysate. This concentration of KC1 was chosen because 
the storage properties of CoA-SPC were shown to be better at 
this concentration than at other KC1 concentrations (63, 64, 
68). At three-hour intervals during the stirring procedure, 
10-ml samples of the crude yeast cell lysate were removed 





OF THE YEAST CELL LYSATEa
Stirring CoA-SPC Soluble Specific
Time Activity Protein Activity
(hours) (nmoles) (mg/ml) (nmoles/mq/h)
0 0 25 0
3 0 26 0
6 8.1 29 5.6
9 14.4 46 5.8
12 30.3 96 6.3
15 36.9 118 6.3
18 37.5 120 6.3
aAt each stirring time indicated, a sample of the crude
homogenate was removed, centrifuged at 105,000 x g for one 
hour at 4°C. The crude extract was assayed for CoA-SPC as 
described under "Assay for CoA-SPC Activity," and for protein 
as described under "Determination of Protein." Activity and 
specific activity calculations are described under "Assay for 
CoA-SPC Activity." 0 indicates no activity.
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extract for assay of soluble protein content and CoA-SPC. 
Although it was observed that stirring was not an absolute 
requirement for the recovery of CoA-SPC activity, since 
simply allowing the crude yeast cell lysate to stand in the 
cold or by bubbling nitrogen or air through the lysate proved 
to be almost as effective, the practice of stirring was 
followed. Table II shows that CoA-SPC activity was first 
detected in the six-hour crude extract. Once activity was 
detected, a progressive increase in activity was observed 
during the ensuing 18 hours of stirring. Although not shown 
in Table II, some CoA-SPC preparations using other sources of 
commercial yeast required additional stirring time for maxi­
mum activity of CoA-SPC, but most preparations showed a pro­
gressive decrease in CoA-SPC activity after 18 hours. The 
18-hour stirring time has resulted in the optimum level of 
CoA-SPC activity for most preparations and has been adopted 
as the time to indicate the optimal level of CoA-SPC activity 
from pellet preparations.
The gradual recovery of CoA-SPC seems to suggest the 
enzyme complex is trapped or attached in some manner in the 
insoluble portion of the yeast cell lysate. There also 
appears to be a requirement for the ether treatment, because 
simply freezing and thawing fresh Bakers' yeast alone or in 
buffer fail to yield CoA-SPC. Likewise, substitution of 
other organic solvents give little or no CoA-SPC activity.
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The requirement for ether therefore, may suggest some altera­
tion of the yeast cell membrane which allows the enzyme 
access to the liquid portion of the cell.
Discovery of the Yeast Component t-Factor
Taking advantage of the observation that CoA-SPC 
appeared to remain within the insoluble fractions of the 
yeast cell lysate prior to stirring, it was hypothesized that 
a simple purification of CoA-SPC could be obtained. The 
approach was simply to separate, by centrifugation, the 
insoluble portion of the yeast cell lysate from the soluble 
portion (crude supernatant liquid). Discarding the crude 
supernatant liquid to remove proteins and other soluble com­
ponents of the yeast cell, followed by washing the pellet 
material to remove loosely bound cellular components, the 
pellet material could then be resuspended in buffer to be 
stirred for 18 hours. This process, however, did not yield 
active CoA-SPC.
The process was reexamined, speculating that a natural 
component of the yeast cell lysate may be involved in the 
solubilization of CoA-SPC. Another possibility was that CoA- 
SPC may be in the soluble fraction of the yeast cell lysate in 
an inactive form. Figure 7 shows a diagrammatic summary of 
the procedures involved, and Table III presents evidence that 






















































Figure 7. Diagrammatic summary of the procedures for 
the preparation of CoA-SPC and involvement of a cellular com­
ponent for its recovery.
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TABLE III









I 18.8 60 6.2
II .7 26 0.6
IIIA 17.9 40 8.9
IIIB 0.4 10 0.8
m e 16.8 30 11.2
aSee Figure 7, "Results and Discussion."
^Measured and calculated according to "Assay for CoA-SPC 
Activity."
94
The yeast cell lysate in Figure 7 was produced by expo­
sure of Bakers' yeast to ether and dry ice as described under 
"Preparation of pellets containing CoA-SPC," and the liqui­
fied cell lysate was divided into three equal parts. One 
portion of the lysate, procedure I, was stirred in the pre­
sence of KC1 for 18 hours. The supernatant liquid produced 
by the 105,000 x g centrifugation step was tested and found 
to contain CoA-SPC activity, as shown in Table III. The 
second portion of the lysate was treated according to proce­
dure II, Figure 7. The crude yeast cell lysate was initially 
centrifuged at 105,000 x g and the pellet material discarded. 
The crude supernatant then had KC1 added in a concentration 
equivalent to 10 mg/ml of yeast cell lysate. The mixture was 
stirred for 18 hours and tested for CoA-SPC activity. As 
shown in Table III, procedure II was essentially void of CoA- 
SPC activity. This confirmed that CoA-SPC was associated 
with the insoluble portion of the lysate and also supported 
the fact that CoA-SPC was not made by catalytic conversion of 
the proenzyme form to the active enzyme form.
The third portion of the crude yeast cell lysate, proce­
dure III, was centrifuged at 1,000 x g for 10 minutes to rid 
the lysate of whole cells and starch added during the pro­
cessing of commercial compressed Bakers' yeast. The 1,000 x 
g pellet material was discarded and the remainder of the sus­
pended lysate was centrifuged at 105,000 x g for one hour.
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The pellet material and crude supernatant liquid were sepa­
rated and saved. The pellet material was washed two times as 
described under "Preparation of pellets containing CoA-SPC." 
The crude supernatant was heat treated as described under 
"Preparation of t-Factor."
In procedure IIIA, Figure 7, page 92, heat treated 
supernatant liquid was combined with washed pellet material. 
Potassium chloride was added and the mixture was stirred for 
18 hours. The supernatant liquid recovered by centrifugation 
as shown in Table III, page 93, contained active CoA-SPC. 
This was very significant since procedure III B was void of 
CoA-SPC activity. Procedure III B was performed by stirring 
for 18 hours washed pellet material suspended in 0.05 M 
sodium acetate, pH 5.8 and KC1. The pH 5.8 was chosen since 
the crude supernatant and heat treat supernatant liquids had 
pH values close to 5.8. In procedure III C, not shown in 
Figure 7, page 92, heat treated supernatant liquid and KC1 
were mixed for an additional 18 hours with the pellet mate­
rial recovered from procedure III B. The supernatant liquid 
recovered from procedure III C contained active CoA-SPC.
The information presented thus far contains two vitally 
important characteristics of CoA-SPC: (1) CoA-SPC appears to 
be bound to or trapped in an extremely heavy, insoluble yeast 
cell component(s), and will remain in that state unless con­
ditions described under procedure I, procedure III A and pro­
cedure III C are followed; and (2) a soluble component(s) of
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the yeast cell is essential for the release or solubilization 
of CoA-SPC. Because the component(s) is yet to be identi­
fied, it will be referred to as t-Factor, named for the 
author, t-Factor does not appear simply to be the autolytic 
enzyme system that digests the complex polysaccharide wall of 
the yeast cell and thus allows the release of CoA-SPC. It has 
been reported that the autolytic enzymes are completely 
inactivated by heating at 60°C for 10 minutes (97). The fact 
that the autolytic enzyme system could play a role in the 
solubilization of CoA-SPC is not discounted. There exist 
cases where organic solvents, such as ether, induce autolysis 
(98). Solvent induced autolysis may activate phospholipases 
and cause disorganization of membrane structure. In the case 
of CoA-SPC solubilization, the ether may render the location 
of CoA-SPC in the yeast cell accessible to t-Factor. 
Although other proteinacous materials are solubilized by the 
stirring process, t-Factor appears to be rather specific for 
the solubilization of CoA-SPC. For instance, protein was 
solubilized in procedure III B, Table III, page 93, by buffer 
and KC1, but the buffer and KC1 did not solubilize CoA-SPC 
until t-Factor was added, procedure IIIC, Table III, page 93.
Since the identity of t-Factor is unknown, its presence 
in a particular fraction of yeast cell supernatant liquid can 
be detected only by indirect assay; that is, assaying for 
activity of CoA-SPC solubilized by t-Factor. The unique role
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t-Factor plays in the yeast cell made it essential to under­
stand further characteristics of the component.
Alternate Methods for the Isolation of t-Factor
Since the data in Table III, page 93, appeared to sug­
gest that the components of t-Factor may be heat stable and 
easily extracted from the yeast cell, an alternate procedure 
for the extraction of t-Factor was attempted (see "Alternate 
Method for the Preparation of t-Factor"). Freezing and thaw­
ing of fresh Bakers* yeast with liquid nitrogen rendered a 
liquified suspension similar to the crude yeast cell lysate 
produced by the ether-dry ice method of preparation. It was 
apparent that some cellular damage had been accomplished by 
this technique based on the protein, and 280 mu and 260 my 
absorbing material in the crude supernatant fraction. How­
ever, when the liquified suspension produced by the liquid 
nitrogen freeze-thaw procedure was stirred in the presence of 
KC1 for 18 hours, no CoA-SPC activity could be detected. 
When the crude supernatant liquid of the liquid nitrogen pro­
cedure was combined with pellet material (see "Preparation of 
pellets containing CoA-SPC") from the ether-dry ice procedure 
and stirred in the presence of KC1 for 18 hours, CoA-SPC was 
solubilized. It was judged at this time that the ether 
treatment was necessary for CoA-SPC to be solubilized by t- 
Factor and that t-Factor was recovered from the yeast cell by 
the liquid nitrogen procedure.
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Although the freeze-thaw method provided by the liquid 
nitrogen treatment was unsuccessful in terms of producing 
CoA-SPC pellets, it did however allow for a more time effi­
cient method for the production and study of t-Factor. Since 
evidence exists that t-Factor was contained in the heat 
treated supernatant liquid of crude yeast cell lysates and 
because of this heat treatment was probably not an autolytic 
enzyme (97) , methods were designed to isolate a pool of t- 
Factor material. Figure 8 shows a diagrammatic summary of 
the techniques used to isolate a pool containing t-Factor.
As shown in Table IV, when heat treated supernatant was 
dialysed according to "Filtration of the t-Factor through 
Dialysis Tubing," the t-Factor activity was shown to be 
present in the material that passed through the membrane. 
Likewise, when heat treated supernatant was filtered accord­
ing to "Cone filtration of t-Factor," the CoA-SPC solubiliz­
ing activity was evident in the filtrate. Since the No. 8 
dialyzing tubing employed in the experiment was supposed to 
retain molecules greater than 20,000 molecular weight, a 
molecular weight of less than 20,000 was suggested for t- 
Factor. However, since vacuum dialysis was employed, the 
stretching of the membrane pores could have allowed molecules 
greater than 20 000 molecular weight to pass into the dialy- 
sate. The activity present in the cone filtrate, however, 
also supported a molecular weight for t-Factor of less than 
25,000. It would have been expected that t-Factor would
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Figure 8. Diagrammatic summary of the procedures for 
the isolation of t-Factor.
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TABLE IV
SOLUBILIZATION OF CoA-SPC WITH VARIOUS SUBFRACTIONS 
OF THE CRUDE SUPERNATANT
Fraction3 CoA-SPCbActivity
(nmoles)





aSee Figure 8, "Results and Discussion." CoA-SPC was 
solubilized by mixing the sub-fraction and KC1 with pellet 
material prepared as described under "Preparation of pellets 
containing CoA-SPC." The mixture was stirred at 4°C for 18 
hours.




remain with the components retained by the cone or retained 
following dialysis if it were a protein, such as a heat 
stable proteolytic enzyme, with a specificity for the solubi­
lization of CoA-SPC.
In a related study (data not shown), it was found that 
if crude supernatant liquid was substituted for heat treated 
supernatant liquid and subjected to dialysis and filtration, 
the resulting filtrate and dialysate showed a decreased solu­
bilization of CoA-SPC. It was therefore speculated that 
endogenous enzymes with the ability to destroy t-Factor may 
be contained in the crude supernatant liquid and as the 
liquid was concentrated by dialysis and filtration, the 
enzyme action on t-Factor was enhanced. Alternatively, it 
was speculated that as the macromolecules were concentrated 
within the bag or cone, t-Factor may bind and not be allowed 
to pass through the membranes. In order to determine which 
speculation was correct, studies were designed in which the 
crude supernatant liquid was incubated at 36°C for two and 
four hours followed by heat treatment. However, this result­
ing supernatant liquid had t-Factor activity. Therefore, 
this study did not support either of the above speculations.
The dialysate or filtrate containing t-Factor was ultra- 
filtered through an Amicon UM-2 filter. Table IV shows t- 
Factor activity was expressed in the filtrate, thus suggest­
ing a molecular weight for t-Factor of less than 1,000. 
Furthermore, when the UM-2 filtrate was passed through the
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UM-05 filter, the t-Factor activity also was contained in 
that filtrate. This suggested a molecular weight of less 
than 500 for t-Factor. It became obvious at this time that t- 
Factor was not a macromolecule but appeared to be a heat 
stable, low molecular weight component; a description used 
frequently to describe cofactors and vitamins. The UM-05 
ultrafilter was tested for its retainability of CoA (mole­
cular weight 767) and angiotensin II (molecular weight 1026). 
Coenzyme A appeared to be freely filterable, but angiotensin 
II was not. It was apparent that the UM-05 filter was not 
completely reliable to prevent the passage of compounds 
greater than 500 molecular weight. Therefore, a reasonable 
estimate for the upper limit of the molecular weight range of 
t-Factor was 1,000.
Effect of Heat on t-Factor
The apparent non-lability of t-Factor demonstrated by 
its presence in the heat treated supernatant was more rigor­
ously examined. Table V shows that heating t-Factor con­
tained in the UM-05 filtrate at 80°C, an additional 24 hours 
beyond the initial heat treatment, resulted in little or no 
loss of t-Factor activity. As shown in Table V, the apparent 
decrease in t-Factor activity was approximately 10 percent 
based on solubilized CoA-SPC activity. This may represent 
inherent characteristics of the recovery procedure for t- 
Factor because in a similar experiment carried out at 100°C, 
parallel results were obtained.
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TABLE V
THE EFFECT OF HEAT ON t-FACTOR ACTIVITY*
Time CoA-SPC Activity3
(hours) (nmoles)
0 2 0 . 6
in•o 1 9 . 4
1 1 9 . 8
3 1 9 . 1
5 1 9 . 0
24 1 8 . 7
it  at-Factor in the UM-05 filtrate was heated at 80 C for 
the period of time indicated. Following the heating proce­
dure, t-Factor was added to pellet material obtained by cen­
trifugation of the crude yeast cell lysate and stirred as 
described under "Assay for t-Factor Activity by the Solubili­
zation of CoA-SPC."
aThe level of CoA-SPC activity was interpreted to be 
directly proportional to the amount of t-Factor stirred with 
the insoluble pellet material. CoA-SPC activity was deter­
mined as described under "Assay for CoA-SPC Activity."
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The UM-05 filtrate was also treated according to the 
methods outlined under "Ashing of t-Factor." When the amber 
solution of UM-05 filtrate was evaporated to dryness and 
charred, heavy black smoke evolved. After ashing at 800°C 
for two hours, the white powder that remained was tested for 
t-Factor activity. Since oxides are formed upon ashing, part 
of the ashed material was insoluble in water. The soluble 
portion of the ashed material was tested for t-Factor acti­
vity as described under "Assay for t-Factor Activity by the 
Solubilization of CoA-SPC." Another portion of the ash was 
dissolved in hydrochloric acid to solubilize oxides of com­
pounds formed. Even in the acid solution, a small amount of 
the material was insoluble. The acid ash was neutralized to 
pH 5.8 and tested for t-Factor activity. Although protein 
material was solubilized from pellet material, no CoA-SPC 
activity was evident. The information provided by ashing the 
UM-05 filtrate would appear to suggest that t-Factor is not 
an inorganic compound such as salt or metal cofactor. 
Although t-Factor activity could have been lost during the 
evaporation procedure or could still be present in the small 
amount of residue not soluble after ashing, the evidence 
suggests t-Factor is probably organic in nature.
Concentration of t-Factor on the Solubilization of CoA-SPC
A relationship between the solubilization of CoA-SPC and 
the amount of t-Factor present was studied. The UM-05
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filtrate employed in this experiment was prepared from a 
crude supernatant of cell lysate that appeared to give opti­
mal CoA-SPC activity after 18 hours stirring (see Table II, 
page 89). Since the composition of t-Factor is unknown and 
at this time cannot be quantitated, dilutions were made with 
water of the t-Factor contained in the UM-05 filtrate. It is 
shown in Table VI that as the t-Factor solution was diluted, 
the level of CoA-SPC activity decreased proportionally. In 
its most diluted form, the t-Factor preparation does not 
solubilize CoA-SPC but other proteins continue to be solubi­
lized. The extraneous proteins solubilized were due to the 
presence of KC1 added when t-Factor activity was assayed. 
Since decreasing the concentration of t-Factor resulted in a 
proportional decrease in the solubilization of CoA-SPC it 
seemed logical that increasing the concentration of t-Factor 
above that which was initially present in the yeast cell 
might increase the amount of CoA-SPC solubilized. These 
studies were repeated using the "charcoal extract" as a 
source of t-Factor (see Table XII, page 127). Although t- 
Factor in the "charcoal extract" was purified to a greater 
extent than in the UM-05 filtrate, a similar pattern of CoA- 
SPC solubilization was obtained related to t-Factor concen­
tration.
Many other low molecular weight components of the yeast 
cell are contained in the UM-05 filtrate. Some of these 
components (i.e., CoA) are inhibitors of CoA-SPC activity.
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TABLE VI
EFFECT OF THE CONCENTRATION OF t-FACTOR 











2.00 28.2 21.0 26.9
1.00 29.6 15.0 39.5
0.75 21.0 13.5 31.3
0.50 15.2 12.0 25.3
0.20 5.7 11.4 10.0
0.10 0.0 10 0.0
aUM-05 filtrate obtained from crude supernatant with 
apparent maximal CoA-SPC solubilizing activity as diluted 
with deionized water. The 1.00 refers to the original con­
centration and the decimal fractions to the dilution? the 
quantity 2.00 refers to the twice concentrated UM-05 fil­
trate. Each sample was assayed for t-Factor activity as 
described in "Materials and Methods, Assay for t-Factor Acti­
vity by the Solubilization of CoA-SPC."
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Thus, when the UM-05 filtrate containing t-Factor is concen­
trated, any inhibitors present are also concentrated, there­
fore the inability to detect increased solubilization of 
additional CoA-SPC by adding higher concentrations of t- 
Factor could be due to an increased concentration of inhibi­
tors on CoA-SPC activity. Although the "charcoal extract” is 
more purified than the UM-05 filtrate, cellular components 
other than t-Factor are present. Consequently, inhibition of 
CoA-SPC activity may still be present in this extract.
Action of Proteolytic Enzymes on t-Factor
The data in Table VII shows that t-Factor is not digest­
ed by either trypsin or protease. Although it was apparent 
by the filterability of t-Factor through the UM-05 that t- 
Factor was not a protein-like molecule, the possiblity did 
exist that t-Factor could be a peptide. It could be argued 
that the large pool of low molecular weight compounds could 
contain other peptides competing with t-Factor for the action 
by the proteolytic enzymes; but since there was not an indi­
cation of any decrease in t-Factor activity, it was concluded 
that t-Factor was not susceptible to attack by these pro­
teases. Therefore, t-Factor apparently contained no peptide 
bonds (protease), or arginine or lysine residues (trypsin).
Preparative Paper Chromatography
When UM-05 filtrates containing t-Factor activity were 
chromatogramed in Solvent I (see "Paper Chromatography"),
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aThe treatments for each of the UM-05 filtrates contain­
ing t-Factor was described under "Proteolytic Treatment of t- 
Factor." Controls were incubated with proteolytic enzymes 
that were first inactivated by boiling. Following the diges­
tion incubations, treated t-Factor solutions were recovered 
for testing by vacuum dialysis.
bThe solutions recovered by vacuum dialysis were tested 
for t-Factor activity as described under "Assay for t-Factor 
Activity by the Solubilization of CoA-SPC."
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ninhydrin positive material was spread from the origin to the 
solvent front in at least thirteen overlapping spots. The 
chromatograms were cut into four segments as shown in Figure 
9; segment 1 = .000 to .075, segment 2 = .075 to .410, 
segment 3 Rf = .410 to .765, and segment 4 R^ = .765 to 1.00. 
The t-Factor was localized in segment 1 of the chromatogram 
run in Solvent I. Although paper chromatography resulted in 
further purification of t-Factor, the material in segment 1 
showed heterogeneity based upon ninhydrin positive, ultra­
violet absorbing, organophosphate compounds and sulfhydryl 
compounds. The abundance of organic phosphate and ultra­
violet absorbing material could be attributed to adenine 
nucleotide compounds that are easily extracted from yeast and 
from the observation that CoA, ATP, AMP, ADP, and cyclic AMP 
all stayed within the R^ zone 0.075 when chromatographed in 
Solvent I. Rechromatography of the extract from segment 1 in 
Solvent II further separated ultraviolet absorbing and nin­
hydrin staining compounds. In this solvent system, t-Factor 
also remained in segment 1 (Rf = .000 to 0.361) (Table VIII).
Elution Pattern of t-Factor on Sephadex G-10
The equivalent of 10 ml of UM-05 filtrate containing t- 
Factor was passed through a Sephadex G-10 column as described 
under "Permeation Chromatography of t-Factor on Sephadex G- 
10." The typical elution pattern as monitored at 260 mp with 
water as the eluent is shown in Figure 10. Although it is not
Location of t-Factor














aSee Figure 9 and "Paper Chromatography" for details of 
segmentation.
Extracts from the paper chromatogram were handled as 
described under "Paper Chromatography" and tested for t- 
Factor activity as described under "Assay for t-FActor Acti­
vity by the Solubilization of CoA SPC."




known whether t-Factor absorbs ultraviolet light at 260 mp, 
other components of the UM-05 filtrate do. To determine the 
portion of the elution volume that contained t-Factor acti­
vity, fractions were pooled, lyophilized and tested for acti­
vity as described under "Assay for t-Factor Activity by the 
Solubilization of CoA-SPC."
The t-Factor active material was eluted in the fraction 
volume 39.6 ml to 51.7 ml shown as the bracket in Figure 10. 
The pattern of 260 my absorbing components of the UM-05 fil­
trate suggests that some of the components may have an affin­
ity for the column matrix. The suggestion arises from the 
fact that the last two eluting peaks require an elution 
volume larger than the total column volume (108 ml) . In an 
effort to minimize these effects, the UM-05 filtrate was 
eluted with 0.03 M KC1, however, no difference in the elution 
pattern of t-Factor or 260 my absorbing compounds were noted. 
Therefore, it was decided to use water as the eluent rou­
tinely.
Paper chromatography of the t-Factor active fraction 
contained contaminating components that absorbed ultraviolet 
light, were ninhydrin positive, and contained organic phos­
phates. Column chromatography of t-Factor purified by paper 
chromatography failed to resolve t-Factor from many of these 
contaminating components (see "Paper Chromatography").
114
Molecular Weight Estimation of t-Factor
A mixture of compounds with strong ultraviolet absorp­
tion at 260 m and of known molecular weights were chromato­
graphed on the Sephadex G-10 column to obtain a calibration 
curve. In Figure 11, the calibration curve is plotted
according to the method of Marzullo et al. (92). The mole­
cular weight assigned to t-Factor based on its elution 
pattern on Sephadex G-10 is approximately 400 to 550 (see 
Figure 10, page 112). However, since compounds as large as 
1,000 molecular weight could be contained in the UM-05 fil­
trate, and since t-Factor activity begins to appear close to 
the void volume of the column, a more liberal molecular 
weight estimate may be 400 to 1,000.
Requirement for KC1 or Chloride Ion
Solubilization of CoA-SPC by t-Factor is enhanced when 
KC1 is added to the mixture (Table IX). Because of the pre­
sence of endogenous chloride ion (average 0.92 mg/ml) in the 
UM-05 filtrate containing t-Factor, some CoA-SPC activity was 
detected without the addition of exogenous KC1 to the 
stirring flask. However, KC1 in H20 or in 0.05 M Tris- 
acetate, pH 7.2, in the absence of t-Factor did not release 
CoA-SPC from yeast pellet material. Although t-Factor is 
required and may be specific for the release of CoA-SPC, the 
amount of protein present in the supernatant fraction follow­










Figure 11. The Sephadex G-10 calibration curve for the estimation of the 
molecular weight of t-Factor.
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+ k n o3 18.9
+ Ca3 (p04)2 0.1
- CaCl2 0.2
a (+) indicate t-Factor added, (-) indicate either t- 
Factor or salt is omitted from the mixture. The average 
endogenous Cl” concentration based on several batches of 
yeast was 0.92 mg/ml of UM-05 filtrate. The 10 mg/ml of 
exogenous KC1 added is based on the total yeast cell suspen­
sion. Other salts tested were adjusted to approximately the 
KC1 concentration.
bKCl in the absence of t-Factor was dissolved in 2 ml of 
H2O and then mixed with pellet material as described under 
"Assay for t-Factor Activity by the Solubilization of CoA- 
SPC. "
c . ,Anions associated with cations such as Li, Hg, Pb, Zn, 
Fe appear to inhibit the catalytic activity of CoA-SPC (66).
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greater than the amount of protein which would be accounted 
for by CoA-SPC alone. Solubilized extraneous protein was 
shown to be due to mechanical stirring and salt concentration 
of the mixture (see Table III, Procedure IIIB, page 93).
The chloride ion, not KC1, appears to be essential for 
the solubilization of CoA-SPC. To investigate this, chloride 
salts other than KC1 were tested. Mono and dichloride salts 
at approximately equivalent chloride ion concentrations were 
mixed with pellet material and t-Factor, and were shown to 
function equally well in the solubilization of CoA-SPC. With 
the exception of KNO^, the addition of salts not containing 
chloride (e.g., KAc, NaAc, Na^O^, KI) did not elevate the 
level of CoA-SPC activity above that shown for endogenous 
chloride (Table IX). Consequently, it would appear that the 
salts tested which do not contain Cl~ or do not function 
for solubilization of CoA-SPC. Utilizing CoA-SPC solubilized 
by t-Factor and KC1, varying amounts of CaCl2 and MnCl2 were 
added to the solubilized CoA-SPC. Because the activity of 
the CoA-SPC was not stimulated by the presence of these two 
salt forms, it was assumed that the difference in CoA-SPC 
activity in Table IX between the KC1 preparations and the 
MnCl2 and CaCl2 were not due to activation. Instead, since 
the salt forms were weighed rather than titrated to the 
appropriate concentrations, an error may have arisen, or the 
inconsistencies of the CoA-SPC content of pellet preparations 
would also cause some could cause variation. Since the
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specific activities were comparable, these differences were 
judged insignificant. In the case of LiCl, the chloride may 
have solubilized the CoA-SPC, but because Li+ is inhibitory 
(66) to the catalytic action of CoA-SPC, no activity would be 
expected.
In other studies, experiments were conducted using 
3 6[ Cl]-NaCl to determine if the chloride ion exerts its 
action by binding to CoA-SPC, heavy components of the yeast 
cell lysate or t-Factor. Results of these experiments did 
not indicate that [ C l  ] was binding to any of these frac- 
tions. Therefore, if [ Cl ] binding does take place, the 
bond between [ C l  ] and its site of binding is broken during 
the recovery of CoA-SPC, other cell components or t-Factor.
Moreover, once t-Factor has been used for the solubili­
zation of CoA-SPC, it may be recovered by vacuum dialysis and 
reused without an apparent loss of activity.
Compounds Tested for t-Factor Activity
Table X shows the various compounds tested for t-Factor 
activity. The biological compounds were selected based on 
their characteristics of molecular weight, heat stability, 
solubility in water, ultraviolet absorption at 260 mu and 
ease of extractability from yeast. The detergents Triton X- 
100, cetylpyridinium chloride (CPC), sodium deoxycholate, and 
the reducing agents ethylenediamine tetracetic acid (EDTA), 
8-mercaptoethanol, and glutathione were also chosen because
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Nicotinamide Adenine Dinucleotide 
(Red) (NADH) -
Nicotinamide Adenine Dinucleotide 
(Ox) (NAD) -
Flavin Mononucleotide (FMN) -
Flavin Adenine Dinucleotide (FAD) -
Nicotinamide Adenine Dinucleotide 
Phosphate (NADP) -
Tetrahydrofolic Acid -








Ethylenediamine Tetracetic Acid (EDTA) -
Glutathione (GSH) -
$-Mercaptoethanol -
Cetylpyridinium Chloride (CPC) -
Triton X-100 -
Each compound was tested by dissolving the compound in 
deionized water to a concentration of 0.1 mg/ml. The deter­
gents and reducing agents were tested at a concentration of 
1 mg/ml. The solution was combined with pellet material con­
taining CoA-SPC and 10 mg KC1 per milliliter of yeast suspen­
sion was added. The suspension was mixed at 4°C for 18 hours 
and centrifuged at 105,000 x g at 4°C for one hour. The 
supernatant was tested for solubilized CoA-SPC as described 
in "Assay for CoA-SPC Activity."
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these agents are commonly used in various systems to solubi­
lize proteins. Each compound was first tested individually 
and then, many were tested as various combinations with other 
compounds in Table X. As Table X shows, none of the compounds 
tested were able to be substituted for t-Factor as measured 
by the indirect assay method.
Testing t-Factor and Solubilized CoA-SPC for Proteolytic 
Activity
In Figure 12, a photograph of the casein agar plate used 
to detect proteolytic activity is shown. The positive and 
negative controls (see "Proteolytic Activity Assessment") are 
contained in Row 3. In Row 3, sample well 2 is the negative 
control, and in sample wells 3, 4, and 5 are progressively 
increasing concentrations of the positive control. The posi­
tive controls show the clearing zone that appears around the 
sample well when proteolytic attack has occurred. Although 
Row 3, sample well 5 was poorly photographed, sample wells 3 
and 4 demonstrate that the diameters of the clearing zones 
are increased when increased proteolytically active enzyme 
are present.
Sample well 3 of Rows 1 and 2 show that crude superna­
tant containing t-Factor has proteolytic activity. Sample 
well 2 of Rows 1 and 2 show that heat treating the crude 
supernatant destroys the proteolytic activity, and the lack 
of proteolytic activity remaining with the UM-05 filtrate
R O W  1
R O W 2
R O W  3
Figure 12. Testing proteolytic activity in various t-Factor fractions and CoA-SPC 
solubilized by crude and purified t-Factor.
The casein agar plate was photographed by direct light; the clearing zones are in 
white and the agar plate in black. The samples were applied to each row in the plate and 
each well assigned a number reading from left to right. Row Is 10 yl UM-05 filtrate? 
10 yl heat treated supernatant? 10 yl crude supernatant? 10 yl crude CoA-SPC? 10 yl 
CoA-SPC solubilized with purified t-Factor. Row 2: Same as Row 1 except the amount 
applied of each sample was 30 yl. Row 3: 30 yl of heat treated CoA-SPC? 30 yl negative 
control? 10 yl positive control? 20 yl positive control? 30 yl positive control.
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(sample 1, Rows 1 and 2). Sample well 4 of Rows 1 and 2 show 
CoA-SPC solubilized with crude t-Factor (crude supernatant) 
and sample well 5 of Rows 1 and 2 show CoA-SPC solubilized by 
t-Factor contained in the UM-05 filtrate.
Comparing the diameters of the clearing zones around 
sample wells 4 and 5, the proteolytic activity shown in the 
CoA-SPC solubilized by purified t-Factor is greatly reduced 
when compared to that solubilized by the crude supernatant. 
The reduced proteolytic activity could provide preparations 
more stable for storage. Since no proteolytic activity is 
added to pellet containing CoA-SPC when purified t-Factor is 
used to solubilize CoA-SPC, it is reasonable to assume that 
the proteolytic activity in sample well 5 is the result of 
the treatment of pellet material with t-Factor and KC1. If 
the solubilization of CoA-SPC is accomplished by the hydro­
lysis of the enzyme from its attachment site in the insoluble 
yeast residue, t-Factor may function to solubilize or acti­
vate a proteolytic enzyme to carry out this function
In Row 3, sample well 1, a sample of heat denatured CoA- 
SPC was applied and no proteolytic activity was evident.
Treatment of t-Factor with Charcoal
Amicon UM-05 filtrate containing t-Factor has signifi­
cant ultraviolet absorption at 260 my. For example, a typi­
cal UM-05 filtrate diluted 100 times has A26Q equal to 1.450, 
therefore the original filtrate contains approximately 145
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absorbance units. After exposure to charcoal (see "Treatment 
of t-Factor with Charcoal") for 30 minutes, the A26Q of the 
"charcoal extract" was decreased to 1.25 absorbance units. 
Longer exposure to the charcoal did not decrease the A26q 
further. Since t-Factor appears in the "charcoal extract", 
this 100-fold decrease in the absorbance would suggest that 
t-Factor does not have the characteristic absorbance or that 
it represents only a small portion of the overall A2^q con­
tent of the UM-05 filtrate. The adsorption step results in a 
further purification of t-Factor. Following this preliminary 
observation on the UM-05 filtrate, the Sephadex G-10 fraction 
containing t-Factor was exposed to charcoal. The charcoal 
removed the ultraviolet absorbing material and the t-Factor 
activity was not decreased from the activity observed in the 
G-10 fraction (see Table XII, page 127).
Treatment of t-Factor with Ion-Exchange Resin
When the "charcoal extract" containing t-Factor activity 
was subjected to ion-exchange chromatography (see Materials 
and Methods, "Treatment of t-Factor with Ion-Exchange 
Resin"); the activity appeared in the "ion-exchange extract". 
The t-Factor activity of this fraction was decreased based on 
its ability to solubilize CoA-SPC. When the "ion-exchange 
eluate" was recombined with the "ion-exchange extract", the 
activity in the original "charcoal extract" was recovered. 
This observation suggests t-Factor may require a second
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component for optimal activity or it may have some affinity 
for the ion-exchange resin (see Table XII).
Purification of t-Factor
The assay for the presence of t-Factor activity is shown 
by the ability of a particular fraction to solubilize cataly- 
tically active CoA-SPC. This indirect method for assay does 
not provide a convenient method for establishing the t-Factor 
content in a particular fraction. To estimate the extent to 
which a particular t-Factor fraction was purified, one must 
first prove that the fraction solubilizes CoA-SPC. Once CoA- 
SPC activity was established, the t-Factor active fraction 
was lyophilized to dryness and weighed. Table XI shows the 
estimated purity of t-Factor by this method as 677-fold over 
crude preparations.
Purification of CoA-SPC Utilizing t-Factor
The evidence presented that t-Factor solubilizes CoA-SPC 
suggested that a single "one-step" purification of CoA-SPC 
could be obtained by combining purified t-Factor with washed 
pellet material obtained from "Preparation of pellets con­
taining CoA-SPC." Table XII shows the purification of CoA- 
SPC with t-Factor obtained from the Sephadex G-10 chromato­
graphy and that following treatment with charcoal provides 
the most pure CoA-SPC preparations. Although the CoA-SPC 
prepared by the t-Factor purified by ion-exchange chromato­
graphy is purified over crude CoA-SPC preparations, the
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TABLE XI
ESTIMATE OF THE PURIFICATION OF t-FACTOR






ml mg mg -fold
Crude supernatant 25 645 3250 1
Heat treated 
supernatant 21.5 150 2400 1.4
Amicon UM-05 
filtrate 10 - 581 5.6
Sephadex G-10 1 - 5.2 625
Charcoal extract 1 _ 4.8 677
aSee Figure 7, page 92, Figure 8, page 99, "Permeation 
Chromatography of t-Factor on Sephadex G-10," and "Treatment 
of t-Factor with Charcoal.”
determined as described under "Determination of Pro­
tein. "
Lyophilized to dryness in tared bottles and weighed.
^Purification is based on the weight ratios of equiva­
lently active t-Factor fractions.
TABLE XII
PURIFICATION OF THE CoA-SYNTHESIZING PROTEIN COMPLEX
(CoA-SPC) BY PURIFIED t-FACTOR
Fraction3 Volume^ Protein9 CoA-SPChActivity
Specific
Activity Yield Purification
ml mg/ml (nmoles) (nmoles/mq/h) % -fold
Crude Extract 175 131.0 28.0 4.4 100 1.0
Pellet Extract
(G-10) 175 4.1 38.0 185.5 132 42.2
Pellet Extract ,
(Charcoal) 175 3.8 35.2 185.5 132 42.2
Pellet Extract
(Ion-Exchange) 175 3.6 26.7 148.4 106 33.8
aEach fraction tested was stirred in the presence of 10 mg KC1 per milliliter of 
yeast suspension for 18 hours at 4°C as described under "Assay for t-Factor Activity by 
the Solubilization of CoA-SPC." The extracts were obtained by centrifugation at
105,000 x g for one hour at 4°C.
This fraction was obtained by stirring the crude yeast cell lysate obtained by 
treatment of the compressed Bakers* yeast with ether and dry ice.
cThis fraction was obtained by mixing pellet material with the t-Factor active 
portion obtained by Sephadex G-10 chromatography of the Amicon UM-05 filtrate. 127
TABLE XII (continued)
dThis fraction was obtained by mixing pellet material with the t-Factor contained 
in "charcoal extract" (see "Treatment of t-Factor with Charcoal").
eThis fraction was obtained by mixing pellet material with the "ion-exchange 
extract" of the "charcoal extract" (see "Treatment of t-Factor with Ion-Exchange 
Resin") .
^Although smaller volumes were used for routine assay for t-Factor activity, 
these volumes are indicative of those recovered from 454 g of Bakers' yeast.
^Determined as described under "Determination of Protein."




procedure is not attractive since there is a decrease in CoA- 
SPC activity when compared to the Sephadex G-10 and charcoal 
preparations.
This method of purification of CoA-SPC utilizing t- 
Factor is attractive from the standpoint that pellets con­
taining CoA-SPC activity may be stored, and purified t-Factor 
added when a CoA-SPC preparation is desired. This initial 
purification may provide a convenient starting point to 
examine other characteristics of CoA-SPC that would otherwise 
require time consuming purification procedures which usually 
result in significant losses of the desired enzyme.
Alternate Method for the Production of CoA-SPC
The ether-solid carbon dioxide method for the production 
of CoA-SPC is satisfactory on a laboratory scale. Therefore, 
it was of interest to learn if other methods of obtaining a 
cell lysate still required t-Factor for the solubilization of 
CoA-SPC. Of the methods attempted, only the alternate method 
as described proved to be successful and has the potential 
for large scale development.
Fresh compressed Bakers' yeast (30 g) was crumbled, 
spread uniformly over the surfaces of three trays and each 
was dried at different temperatures as shown in Table XIII. 
The attempt to dry yeast at 4°C for 72 hours with or without 
vacuum (30 p.s.i.) was not successful. Only 25.80 percent of 
the weight was lost after 72 hours, and no detectable CoA-SPC
TABLE XIII
EFFECT OF DRYING TIME AND TEMPERATURE ON EXTRACTION 
OF CoA-SPC FROM FRESH BAKERS' YEAST
DRYING TEMPERATURE*
4f__________________  _________________ 24f_________________  _________________ 50°
REHYDRATION TEMPERATUREb
if__________________  __________________ 4°_________________  4°





























12 95.64 0 2 0 53.00 9.9 40 5.0 33.70 23.5 68 6.9
24 91.46 0 19 0 37.70 13.0 50 5.2 31.60 23.5 69 6.8
36 87.12 0 11 0 34.00 21.1 61 6.9 31.60 23.5 69 6.8
48 83.60 0 11 0 33.70 23.5 68 6.9 31.20 23.5 63 7.5
60 78.90 0 11 0 33.90 21.1 61 6.9 31.00 23.5 64 7.3
72 74.20 0 11 0 34.10 21.1 61 6.9 31.00 23.5 50 9.4
+Drying was accomplished by crumbling fresh Bakers' yeast and spreading the yeast to a uniform surface in glass or plastic 
trays.
Extraction of CoA-SPC was carried out on the yeast cell lysate by mechanical mixing at 4° for 18 h with 10 mg KCl/ml of 
rehydrated yeast suspension. Centrifugation followed at 105,000 x g one hour at 4°C to recover the liquid portion of the rehy­
drated mixture.
hRehydration was accomplished utilizing deionized H-0 in a volume equivalent to the weight loss during the drying process. 
With the notable exception that the weight lost due to moisture by the yeast dried at 4° was insufficient for mechanical mixing 
to be achieved when rehydrated, additional deionized water was added to the yeast paste. All dried yeast solids were ground 
with a porcelain mortar and pestle at 24° prior to rehydration.
cThe initial weight of the fresh compress Bakers' yeast was 30 g; 26 ml yeast cell volume.
dAs described under "Assay for CoA-SPC Activity," the values listed represent the formation off35S)-dephospho-CoA-bound 
to CoA-SPC.
eSoluble protein measurements are described under "Determination of Protein."
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activity was obtained. If the drying time had been extended, 
CoA-SPC activity may have been observed. The highest CoA-SPC 
activity was obtained when the yeast was dried at 50°C for 72 
hours; however, the activity level of various preparations 
was inconsistent. The most consistent specific activity 
level for CoA-SPC was observed when yeast was dried at 24°C 
for 36 hours to 72 hours. Forty hours at 24°C was chosen as 
the drying conditions for this study. If faster drying rates 
are desired, it is possible to dry the yeast in a vacuum while 
maintaining the yeast temperature at a level at which auto­
lysis occurs.
As the yeast dried, its color darkened. Yeast (30 g) 
was dried until at least 66 percent of its original wet 
weight was removed (Table XIII). Some of the weight remain­
ing was attributed to water (approximately three percent) and 
to starch and other components of the growth medium present 
in the commercial yeast cake. After drying, the yeast was 
used immediately for the preparation of CoA-SPC, or it was 
stored under dry conditions for an extended time without 
harmful effects to its CoA-SPC content.
Preparation of the CoA-SPC was facilitated by grinding 
the dried yeast with a mortar and pestle, or by some other 
method, until the yeast appeared as a uniform powder prior to 
rehydration. The grinding process appeared to facilitate 
rehydration and had a destructive effect on the cell wall.
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Table XIV compares recovery of CoA-SPC from yeast pre­
pared by the original method using ether-solid C02 with CoA- 
SPC recovered by the alternate procedure before and after 
grinding. As shown, grinding of the dried yeast did not 
appear to be essential. Whether the standard procedure of 
grinding with a mortar and pestle was used, or alumina or 
sand paper was used to facilitate cell breakage, the amount 
of CoA-SPC activity recovered was approximately the same. 
Moreover, approximately the same level of CoA-SPC activity 
was recovered from the yeast whether the original method or a 
modified procedure was used.
It was interesting to note that yeast dried by lyophili- 
zation instead of by the slow drying process used in the 
modified procedure did not have CoA-SPC activity whether 
ground or not ground. Slow drying at higher temperatures 
appeared to provide a condition favorable for the autolytic 
process in the yeast cell which contributed to the recovery 
of CoA-SPC.
Experiments studying the effect of grinding on the 
recovery of CoA-SPC are shown in Table XV. There was a dif­
ference in the level of CoA-SPC activity recovered between 
unground (particle size 5600 p to 425 p) yeast and ground 
(particle size 425 P to 125 P, and 125 P to 38 P) yeast. 
Ground Bakers* yeast of particle size ranging from 425 P to 
38 p yielded the greatest amount of CoA-SPC activity. There­
fore, these data indicate that there was a decided advantage
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TABLE XIV
EFFECT OF GRINDING ON THE ABILITY TO EXTRACT 







Original Method*3 25.6 74 6.9
No grinding0 15.3 68 4.5
Grinding with mortar , 
& pestle0 27.1 75 7.2
Grinding with one part 
alumina & nine parts
dry yeast solide 29.4 81 7.3
Grinding freeze-dried f
yeastr 0 81 0
Sandpaper disc^ 25.9 80 6.5
aRehydration by adding deionized H2O (4°C) equivalent to 
the weight lost by drying 30 g compressed yeast. Following 
the addition of H20, the yeast was mixed 18 hours at 4°C with 
10 mg/ml of yeast suspension, centrifuged at 105,000 x g for 
one hour at 4°C to recover the soluble portion.
^Fresh Bakers' yeast was prepared by the ether-solid C02 
method (see "Preparation of pellets containing CoA-SPC").
cDried yeast solids (34 percent of the original wet 
weight) were rehydrated without grinding following the drying 
period.
The yeast solids were ground for approximately Jive 
minutes by hand with a porcelain mortar and pestle at 24°C.
eAlcoa chromatographic alumina F-20 was not removed 
prior to rehydration and mixing.
fCompressed yeast was shell frozen and lyophilized to 
dryness and ground prior to rehydration.
gCoarse sand paper glued to the bottom of a container 
and to the flat surface of a disc which was attached to a 
drill press was used to grind the dried yeast. The dried 
yeast was sandwiched between these two sandpaper discs and 
ground for five minutes at low speed to prevent the genera­
tion of excess heat.
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TABLE XV
EFFECT OF PARTICLE SIZE OF DRIED BAKERS' YEAST 
ON THE EXTRACTION OF CoA-SPC^









5600 - 425 15.3 68 4.5
425 - 125 22.7 76 6.0
125 - 38 28.4 84 6.8
aDried, unground Bakers' yeast (34 percent of the ori­
ginal wet weight) contained particles ranging from 5600 
microns to 88 microns. Ground Bakers' yeast contained parti­
cles ranging from 425 microns to 38 microns. Particle sizes 
were determined through use of the U. S. Standard Sieve 
Series, W. S. Tyler Company. Grinding was achieved by use of 
a porcelain mortar and pestle at 24°C. Extraction of CoA-SPC 
was with deionized ^ 0  at 4°C, followed by mixing for 18 
hours at 4°C with 10 mg KC1 per milliliter of yeast suspen­
sion. The soluble portion was recovered by centrifugation at
105,000 x g for one hour at 4°C.
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to grinding the dried yeast which contributed to the destruc­
tion of the cell wall, and that the more extensive the grind­
ing procedure, the more efficient the recovery of CoA-SPC.
The dried yeast powder was rehydrated by the addition of 
an amount of deionized water equivalent to the original 
weight of the compressed yeast (34 percent). As shown in 
Table XVI, rehydration to 34 percent yeast solids was the 
chosen condition. Higher concentrations of yeast were more 
difficult to stir, and the amount of CoA-SPC recovered was 
less. Whereas, lower concentrations of yeast solids resulted 
in decreased concentration of t-Factor below that essential 
for CoA-SPC solubilization. The rehydration process was con­
ducted at 4°C as shown in Table XIII, page 130. Rehydration 
temperature of 4°C to 65°C were tested as shown in Table 
XVII; however, the most effective temperature range was 
between 4°C and 24°C. After the addition of water, the mix­
ture was stirred until the yeast was uniformly resuspended. 
Then KC1 was added to a concentration of 10 mg/ml of yeast 
suspension of wet yeast and the stirring was continued for 18 
hours at 4°C. Temperatures other than 4°C (i.e., 24°C and 
36°C) were tested during the stirring step, but the alterna­
tive temperatures were detrimental to CoA-SPC (Table XVIII). 
Following the 18-hour stirring step, the mixture was centri­
fuged at 105,000 x g for one hour at 4°C. The supernatant 
liquid was recovered and the protein content and CoA-SPC
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TABLE XVI
EFFECT OF THE CONCENTRATION OF DRIED BAKERS' YEAST SOLIDS 










34 23.5 68 6.9
20 4.0 27 3.0
17 0.9 14 1.3
15 0 13 0
10 0 10 0
8.5 0 6 0
aDried Bakers' yeast solids (34 percent of the original
we£ weight) were ground with a porcelain mortar and pestle at 
24°C to a particle size range of 425 microns to 38 microns. 
The yeast particles were rehydrated with deionized H20 at 4°C 
to the concentrations prescribed based on weight. z KC1 was 
added to each yeast suspension at a concentration of 10 mg/ml 
of yeast suspension. The yeast suspension was mixed at 4°C 
for 18 hours and the soluble portion Recovered by centrifuga­
tion at 105,000 x g for one hour at 4°C. A normal suspension 
of ground Bakers' yeast solids was 34 percent (w/w).
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TABLE XVII
EFFECT OF THE TEMPERATURE OF THE WATER OF 
REHYDRATION ON THE EXTRACTION OF CoA-SPC 










4 25.6 74 6.9
24 25.6 76 6.7
36 22.5 75 6.0
50 18.7 76 4.9
65 0 32 0
aDeionized H20 (66 percent by weight) was added at the 
prescribed temperature to dried ground (particles ranged from 
425 microns to 38 microns) Bakers' yeast solids equivalent to 
the weight lost during the drying procedure. KC1 was added 
to a concentration of 10 mg/ml of yeast suspension and the 
suspension was mixed at 4°C for 18 hours. The soluble por­
tion was recovered by centrifugation at 105,000 x g for one 
hour at 4°C.
^The water and dried (34 percent of the original wet 
weight) Bakers' yeast admixtures were maintained at the indi­
cated water temperature until all solids were suspended.
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TABLE XVIII
EFFECT OF TEMPERATURE FOR MIXING THE REHYDRATED DRIEjD 









ifci (nmoles) (mg/ml) (nmoles/mg/h)
4 25.6 74 6.9
24 0 76 0
36 0 75 0
aDried Bakers* yeast (34 percent at the original wet 
weight) was ground at 24°C to a particle size range of 425 
microns to 38 microns and rehydrated at 4°C with deionized 
H20. KC1 was added to a concentration of 10 mg/ml of yeast 
suspension. Each suspension was mixed at the prescribed 
temperature for 18 hours. The soluble portion was recovered 
by centrifugation at 105,000 x g for one hour at 4°C.
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activity were determined as described under "Materials and 
Methods."
Table XIX shows the effect of initially removing t- 
Factor from the Bakers' yeast cells. Freezing and thawing 
fresh Bakers' yeast in liquid nitrogen as shown in Figure 8, 
page 99, produces insoluble and soluble portions of the yeast 
cell when centrifuged at 105,000 x g at 4°C. The resulting 
supernatant liquid was treated according to the methods out­
lined in Figure 8, page 99, to yield the UM-05 filtrate. The 
insoluble residue was washed twice as described under "Pre­
paration of pellets containing CoA-SPC," and then dried for 
40 hours at 24°C. Table XIX shows that by recombining the UM- 
05 filtrate with the liquid nitrogen-treated dried yeast cell 
residues, CoA-SPC was solubilized. When the dried residues 
were mixed with water and KC1, no CoA-SPC activity was 
detected. Although CoA-SPC was not detected after simply 
stirring the liquid nitrogen freeze-thaw lysate, the drying 
of the residue appeared to render CoA-SPC accessible to t- 
Factor.
Attempts to extract CoA-SPC from Bakers' yeast cells by 
methods other than the two described have failed to yield 
active CoA-SPC. Passage of yeast cells through a French 
pressure cell under 20,000 p.s.i., have failed to produce 
active CoA-SPC before and after stirring for 18 hours. 
Although yeast cells are very difficult to rupture by this 
technique, requiring as much as 50,000 p.s.i. (99), the heat
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EFFECT OF THE INITIAL REMOVAL OF t-FACTOR OF FRESH 
BAKERS' YEAST ON THE EXTRACTION OF CoA-SPC FROM 
THE REMAINING DRIED SOLID RESIDUE
TABLE XIX
Condition CoA-SPC Soluble SpecificActivity Protein Activity
(nmoles) (mg/ml) (nmoles/mg/h)
Control3 23.5 68 6.9
Deionized water & ,
dried yeast residue 0 5 0 .0
Amicon UM-05 filtrate &
dried yeast residue 29.0 10 58.0
aDried Bakers' yeast (34 percent of the original wet 
weight) was ground at 24°C to a particle size range of 425 
microns to 38 microns and rehydrated with deionized water at 
4°C. KC1 was added to the suspension at a concentration of 
IQ mg/ml of yeast suspension. The suspension was mixed at 
4°C for 18 hours. The soluble portion was recovered by cen­
trifugation at 105,000 x g for one hour at 4°C.
bDried yeast residue obtained from the insoluble portion 
of the liquid nitrogen freeze-thaw procedure was ground to a 
particle size of 425 microns to 38 microns. Deionized water 
at 4°C was added to the dried yeast residue (9.5 g) to obtain 
a total volume of 26 ml. KC1 was added to a concentration of 
10 mg/ml yeast suspension and mixed for 18 hours at 4°C. 
Mixing was followed by centrifugation at 105,000 x g for one 
hour at 4°C to obtain the liquid portion.
cDried yeast residue obtained from the insoluble portion 
of the liquid nitrogen freeze-thaw procedure was ground to a 
particle size of 425 microns to 38 microns. Amicon UM-05 
filtrate obtained from the liquid nitrogen freeze-thaw proce­
dure was added at 4°C to the dried yeast residue (9.5 g) to 
obtain a total volume of 26 ml. KC1 was added to a concentra­
tion of 10 mg/ml of yeast suspension and mixed for 18 hours 
at 4°C. Mixing was followed by centrifugation at 105,000 x g 
for one hour at 4°C to obtain the liquid portion.
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generated at 20,000 p.s.i. was sufficient to denature CoA- 
SPC. Likewise, when yeast cells were subjected to sonic 
oscillations, no CoA-SPC activity could be detected before or 
after stirring. The classic autolytic method of incubating 
yeast cells with toluene at 30°C (100) was also ineffective 
for the recovery of CoA-SPC.
CHAPTER V
SUMMARY
The investigations contained in this dissertation demon­
strate two methods for the recovery of coenzyme A-synthesiz- 
ing protein complex (CoA-SPC). The first method involves the 
exposure of Bakers* yeast cells to ether and solid-CC^, and 
the second method involves the slow drying and rehydration of 
the dried yeast cells. Both methods require stirring for 18 
hours for the gradual solubilization of the CoA-SPC. The 
CoA-SPC has been shown not to be catalytic in an iji vitro 
system until first solubilized. The solubilization of CoA- 
SPC was found to require a low molecular weight component of 
the soluble portion of the yeast cell, named t-Factor.
According to these data, there appeared to be a common­
ality between the ether and solid-C02 method, and the alter­
nate method of slow drying and rehydration of yeast cells. 
Both procedures provided a number of biochemical and physical 
disorganizing effects to the very complex protein-polysaccha­
ride lattice of the cell wall for the extraction of CoA-SPC. 
For instance, the breakdown of phospholipids by phospholipase 
C (101) has been observed upon drying the yeast. Addition­
ally, it has been established that diethyl ether and ethanol 
stimulate enzymatic degradation of phospholipids by yet
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unknown mechanisms (98). Other organic solvents such as 
chloroform, toluene and ethylacetate have been employed to 
initiate autolysis for the isolation of proteases (102), 
cytochrome C (103) , 3-fructofuranosidase and acid phosphatase
(104) . These solvents probably release various hydrolytic 
enzymes from organelles that function to lysis intact cells
(105) .
Although the exact nature of the mechanisms involved for 
the extraction of CoA-SPC from ether-solid CO2 treated cells 
and dried-rehydrated treated cells has not been established, 
the presence of t-Factor appeared to be essential. t-Factor 
has not been identified but t-Factor has been purified and 
several of its properties examined. The t-Factor has been 
purified by heat fractionation, dialysis, ultrafiltration, 
column chromatography, adsorption chromatography, paper 
chromatography and ion-exchange chromatography. The t-Factor 
was resistant to heat at 80°C for 24 hours and hydrolysis by 
trypsin and protease? its activity was destroyed by ashing. 
The molecular weight of t-Factor was estimated to be 400 to
1,000 by column chromatography. The solubilization of CoA- 
SPC by t-Factor appeared to be concentration-dependent and 
required the presence of chloride ion. Little is known about 
the mechanism by which t-Factor solubilizes CoA-SPC. How­
ever, if the solubilization is by enzymatic action, t-Factor 
could function as an activator for an enzyme which is also
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insoluble and closely associated with CoA-SPC in the insolu­
ble portion of the yeast cell. The role of the chloride ion 
may be as an inorganic activator of the closely associated 
enzyme.
It would appear that any method of cell breakage 
assisted by endogenous enzyme activity which neither dena­
tures the multienzyme complex, nor destroys t-Factor could be 
a means for recovering CoA-SPC. Although no evidence is 
available at this time, the possibility still remains that 
CoA-SPC is compartmentalized in the yeast cell and not bound. 
If this should be the case, then any method which ruptures 
the subcellular organelles and is not destructive to CoA-SPC 
activity could produce an active preparation of this multi­
enzyme complex. The drying and grinding procedures described 
appeared to have an effect on the yeast cell similar to that 
of the original procedure of freezing the yeast in ether and 
solid C02- Neither method denatured CoA-SPC and both methods 
rendered CoA-SPC accessible to solubilization by t-Factor. A 
distinct advantage to the drying-rehydration procedure was 
realized when small preparations of CoA-SPC were scaled up to 
commercial size batches not requiring the large volume of 
ether necessary in the original method.
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